ࡱ> HJEFGM[  bjbjcTcT <>>%SU e u u u $ P # KI&G,(o,o,,s.iG$Nu !Rs.s.!R!Ru u o,,SSS!R<u o,u ,S!RSS.~Ho,;r ]SƝ@ڵ0K 5]Sp55u !R!RS!R!R!R!R!RS!R!R!RK!R!R!R!R5!R!R!R!R!R!R!R!R!R : GHTF/SG3/N18:2010  FINAL DOCUMENT Global Harmonization Task Force Title: Quality management system Medical Devices Guidance on corrective action and preventive action and related QMS processes Authoring Group: Study Group 3 Date: 4 November 2010 Dr. Larry Kelly, GHTF Chair The document herein was produced by the Global Harmonization Task Force, which is comprised of representatives from medical device regulatory agencies and the regulated industry. The document is intended to provide non-binding guidance for use in the regulation of medical devices, and has been subject to consultation throughout its development. There are no restrictions on the reproduction, distribution or use of this document; however, incorporation of this document, in part or in whole, into any other document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the Global Harmonization Task Force. Copyright 2010 by the Global Harmonization Task Force Table of Contents  TOC \o "1-3" \h \z \u HYPERLINK \l "_Toc264194073"Preface  PAGEREF _Toc264194073 \h 3 HYPERLINK \l "_Toc264194074"Introduction  PAGEREF _Toc264194074 \h 3 HYPERLINK \l "_Toc264194075"1.0 Scope  PAGEREF _Toc264194075 \h 4 HYPERLINK \l "_Toc264194076"2.0 Definitions  PAGEREF _Toc264194076 \h 4 HYPERLINK \l "_Toc264194077"2.1 Correction  PAGEREF _Toc264194077 \h 4 HYPERLINK \l "_Toc264194078"2.2 Corrective action  PAGEREF _Toc264194078 \h 4 HYPERLINK \l "_Toc264194079"2.3 Data Sources  PAGEREF _Toc264194079 \h 4 HYPERLINK \l "_Toc264194080"2.4 Concession  PAGEREF _Toc264194080 \h 4 HYPERLINK \l "_Toc264194081"2.5 Preventive action  PAGEREF _Toc264194081 \h 5 HYPERLINK \l "_Toc264194082"2.6 Nonconformity  PAGEREF _Toc264194082 \h 5 HYPERLINK \l "_Toc264194083"2.7 Verification  PAGEREF _Toc264194083 \h 5 HYPERLINK \l "_Toc264194084"2.8 Validation  PAGEREF _Toc264194084 \h 5 HYPERLINK \l "_Toc264194085"3.0 Overview  PAGEREF _Toc264194085 \h 5 HYPERLINK \l "_Toc264194086"4.0 Phase I: Planning  PAGEREF _Toc264194086 \h 7 HYPERLINK \l "_Toc264194087"4.1 Plan for Measurement, Analysis and Improvement Processes  PAGEREF _Toc264194087 \h 8 HYPERLINK \l "_Toc264194088"4.2 Establish Data Sources and Criteria  PAGEREF _Toc264194088 \h 9 HYPERLINK \l "_Toc264194089"5.0 Phase II: Measurement and Analysis within and across Data Sources  PAGEREF _Toc264194089 \h 10 HYPERLINK \l "_Toc264194090"5.1 Measure  PAGEREF _Toc264194090 \h 10 HYPERLINK \l "_Toc264194091"5.2 Analyze  PAGEREF _Toc264194091 \h 10 HYPERLINK \l "_Toc264194092"6.0 Phase III: Improvement  PAGEREF _Toc264194092 \h 14 HYPERLINK \l "_Toc264194093"6.1 Investigate  PAGEREF _Toc264194093 \h 14 HYPERLINK \l "_Toc264194094"6.2 Identify Root Cause  PAGEREF _Toc264194094 \h 16 HYPERLINK \l "_Toc264194095"6.3 Identify Actions  PAGEREF _Toc264194095 \h 17 HYPERLINK \l "_Toc264194096"6.4 Verify Identified Actions  PAGEREF _Toc264194096 \h 18 HYPERLINK \l "_Toc264194097"6.5 Implement Actions  PAGEREF _Toc264194097 \h 18 HYPERLINK \l "_Toc264194098"6.6 Determine Effectiveness of Implemented Actions  PAGEREF _Toc264194098 \h 19 HYPERLINK \l "_Toc264194099"7.0 Phase IV: Input to Management  PAGEREF _Toc264194099 \h 19 HYPERLINK \l "_Toc264194100"7.1 Report to Management  PAGEREF _Toc264194100 \h 19 HYPERLINK \l "_Toc264194101"7.2 Management Review  PAGEREF _Toc264194101 \h 20 HYPERLINK \l "_Toc264194102"Annex A: Examples of Phase Activities  PAGEREF _Toc264194102 \h 21 HYPERLINK \l "_Toc264194103"Annex B: Examples of Data Sources and Data Elements  PAGEREF _Toc264194103 \h 22 HYPERLINK \l "_Toc264194104"Annex C: Examples of Contributing Factors  PAGEREF _Toc264194104 \h 24 HYPERLINK \l "_Toc264194105"Annex D: Examples for Documentation of the Improvement Processes  PAGEREF _Toc264194105 \h 25  Preface The document herein was produced by the Global Harmonization Task Force, a voluntary group of representatives from medical device regulatory agencies and the regulated industry. The document is intended to provide non-binding guidance for use in the regulation of medical devices, and has been subject to consultation throughout its development. There are no restrictions on the reproduction, distribution or use of this document; however, incorporation of this document, in part or in whole, into any other document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the Global Harmonization Task Force. Introduction This guidance document is intended for medical device manufacturers and regulatory authorities. It is intended for educational purposes and is not intended to be used to assess or audit compliance with regulatory requirements. It is expected that the reader is familiar with regulatory Quality Management System (QMS) requirements within the medical devices sector. For the purposes of this document it is assumed that the medical device manufacturer has a QMS which requires the manufacturer to have documented processes to ensure that medical devices placed on the market are safe and effective. For example ISO13485 Medical Devices Quality Management Systems Requirements for regulatory purposes, Japanese Ministerial Ordinance on Standards for Manufacturing Control and Quality Control for Medical Devices and in vitro Diagnostics (MHLW Ministerial Ordinance No. 169), the FDA Quality System Regulation 21 CFR Part 820 or the respective quality system requirements of the European medical Device Directives. For this purpose the manufacturer will establish processes and define appropriate controls for measurement and analysis to identify nonconformities and potential nonconformities. Also, the manufacturer should establish processes defining when and how corrections, corrective actions, or preventive actions should be undertaken. These actions should be commensurate with the significance or risk of the nonconformity or potential nonconformity. The terms risk, risk management and related terminology utilized within this document are in accordance with ISO 14971 Medical Devices-Application of Risk Management to Medical Devices. The acronym CAPA will not be used in this document because the concept of corrective action and preventive action has been incorrectly interpreted to assume that a preventive action is required for every corrective action. This document will discuss the escalation process from different reactive sources which will be corrective in nature and other proactive sources which will be preventive in nature. The manufacturer is required to account for both types of data sources whether they are of a corrective or preventive nature. Regardless of the nature of the data source, if there is a decision to escalate the information to further evaluation and investigation, the steps of investigation, identification of root causes and actions needed, verification, implementation, and effectiveness checks will be similar. This guidance document will describe measurement, analysis and improvement as complete and integrated processes. Scope This document provides guidance for establishing adequate processes for measurement, analysis and improvement within the QMS as related to correction and/or corrective action for nonconformities or preventive action for potential nonconformities of systems, processes or products. Definitions The references to clauses in this section refer to ISO 9000:2005. Correction Action to eliminate a detected nonconformity (3.6.2) Note 1 A correction can be made in conjunction with corrective action (3.6.5) Note 2 Corrections can be, for example, rework (3.6.7) or re-grade (3.6.8) Corrective action Action to eliminate the cause of a detected nonconformity (3.6.2) or other undesirable situation Note 1 There can be more than one cause for nonconformity Note 2 Corrective action is taken to prevent recurrence whereas preventive action (3.6.4) is taken to prevent occurrence Note 3 There is a distinction between correction (3.6.6) and corrective action Data Sources The processes within a Quality Management System that provide quality information that could be used to identify nonconformities, or potential nonconformities Concession Permission to use or release a product that does not conform to specified requirements (3.6.11). Preventive action Action to eliminate the cause of a potential nonconformity (3.6.2) or other undesirable situation Note 1 There can be more than one cause for nonconformity Note 2 Preventive action is taken to prevent occurrence whereas corrective action (3.6.5) is taken to prevent recurrence Nonconformity Non fulfillment of a requirement (3.1.2) Verification Confirmation through provision of objective evidence (3.8.1) that specified requirements (3.1.2) have been fulfilled Note 1 The term verified is used to designate the corresponding status. Note 2 Confirmation can comprise activities such as: - performing alternative calculations, - comparing a new design specification (3.7.3) with a similar proven design specification, undertaking tests (3.8.3), performing demonstrations, and reviewing and approving documents prior to issue. Validation Confirmation through provision of objective evidence (3.8.1) that the requirements for a specific intended use or application have been fulfilled Note 1 The term validated is used to designate the corresponding status. Note 2 The use conditions for validation can be real or simulated. Overview The manufacturer is responsible for the implementation and maintenance of a QMS which enables their organization to provide safe and effective medical devices meeting customer and regulatory requirements. A nonconformity as defined in  REF _Ref241459143 \r \h \* MERGEFORMAT 2.6 is a non fulfillment of a requirement. It is important to understand that requirements may relate to product, process or the QMS. When a nonconformity is identified, the manufacturer will determine the significance, the associated risk and the potential for recurrence. Once these have been determined the manufacturer may decide the nonconformity has little associated risk or is unlikely to recur. In such cases the manufacturer may decide only to carry out a correction. Should the nonconformity recur within the QMS, during manufacture or after the medical device has been delivered to a customer, it is an indication that improvement action(s) may be needed. In either case the QMS requires that a corrective action should be carried out with the aim to prevent recurrence. The corrective action may be as simple as retraining, or as complex as redesigning the manufacturing process. The manufacturer may encounter situations that have not actually caused a nonconformity, but may do so in the future. Such situations may call for preventive action. For example, production or acceptance testing trend data indicates that control limits are being approached and revision of product or production (process, equipment or facilities) requirements may be necessary. These revisions could constitute a preventive action. Preventive action would not include planned process adjustments intended to return process performance to nominal values from the edges of the process control range. Actions taken to eliminate observed nonconformities within the scope of a single QMS (regardless of whether the actions are taken at more than one site or facility operating within that QMS) would be considered corrective actions. However, similar actions applied within another QMS (regardless of whether it is the same site, facility, or organization) that has not yet experienced these nonconformities, would be considered preventive actions. Figure 1 illustrates typical Phases to be considered when planning, implementing and maintaining effective processes for measurement, analysis, improvement and providing input to management. See Annex A for a list of possible activities corresponding to the phases in Figure 1. As a check on the effectiveness of the processes defined, management should regularly review the outputs of processes and make adjustments as needed. Documented procedures, requirements and records should be maintained by the manufacturer to ensure and demonstrate the effective planning, operation and control of the processes. Documented evidence of decisions and actions taken will be a part of the QMS.  EMBED Visio.Drawing.11  Figure 1: Processes for measurement, analysis and improvement Phase I: Planning Planning involves specifying processes and associated resources in order to meet specific objectives. Factors to consider during the planning phase should be aligned with the manufacturers overall business planning and include the devices intended use, markets and users, as well as regulatory requirements. The involvement of management at appropriate levels (e.g. review, approval) in actions taken in response to nonconformities or potential nonconformities should be established. Management should ensure that measurement criteria are defined for identified data sources and communicated across the organization. Plan for Measurement, Analysis and Improvement Processes Factors to consider during this planning phase should be aligned with the manufacturers overall business planning and as a minimum include the type of device being manufactured, intended markets and users, and regulatory requirements. As part of planning, management should review the processes critical to the operations with regard to quality and regulatory requirements and select relevant data sources to measure, analyze and facilitate improvement as necessary. In the process of planning measurement and analysis, a manufacturer needs to take into account data sources, the measurement of the data elements within each data source, the frequency of monitoring, and the analysis to be performed within a data source, or across data sources. The measurement of data elements should be done in a way that ensures the manufacturer is effective in managing the operations and maintain an effective QMS. Each of the data elements should be planned and established with specific requirements for measurement that are monitored routinely. The scope of the QMS and the scope of the measurement, analysis and improvement processes will provide the boundaries as to whether the data source is reactive/corrective or proactive/preventive. The planning phase should ensure the following: Identification of relevant internal and external data sources that are indicators of process and product performance. Provision for adequate resources and establish responsibilities and authorities to enable the necessary actions. Resources may include technical experts, testing laboratories, data management, infrastructure, training, etc. Definition of requirements for each identified data source, including limits, acceptance criteria, escalation criteria and mechanisms for reporting of nonconformities or potential nonconformities. Analysis of data elements within data sources. Coordination and analysis of data across data sources. For each data element individual criteria should be defined; however, criteria may be defined for a combination of data elements. Criteria should be quantitative whenever possible in order to maximize consistency and reproducibility for subsequent analysis. If the criteria and data are qualitative, subjectivity should be eliminated or minimized. Acceptance criteria should be based on system, product and process specifications or requirements which are typically identified during design and development activities. This includes the design of the Quality Management System, development and maintenance of assembly processes, delivery processes, servicing and installation processes. Escalation criteria used for the purpose of initiating the improvement process (see  REF _Ref241461027 \w \h \* MERGEFORMAT 6.0) may often be called action levels, trigger points, thresholds, etc. These escalation criteria should be proceduralized and would likely include certain generic action levels as well as specific action levels resulting from risk management activities. In particular, criteria should be established for immediate escalation. For example, an incident alleging a death or serious injury should be escalated to the improvement phase (see 6.0) for immediate action. For new technology and existing technologies with new intended uses/applications, initial escalation criteria may be difficult to define for the monitoring process. Therefore a manufacturer should plan for resources to analyze information in order to confirm initial assumptions and establish or revise escalation criteria. Planning should provide for confirmation that the defined limits, acceptance criteria, escalation criteria and mechanisms for reporting of nonconformities or potential nonconformities for the original data sources and data elements are still appropriate. Where new data sources need to be established, confirm that they have been identified and their criteria defined. Establish Data Sources and Criteria The manufacturer should identify and document relevant data sources and their data elements, both internal and external to the organization. Data elements provide information regarding nonconformities, potential nonconformities and the effectiveness of the established processes within the data sources. Examples of data sources can be, but are not restricted to: Regulatory Requirements Management Review Supplier (performance/controls) Complaint Handling Adverse Event Reporting Process Controls Finished Product Quality Audits (internal/external) Product Recall Spare Parts Usage Service Reports Returned Product Market/Customer Surveys Scientific Literature Media Sources Product Realization (design, purchasing, production and service and customer information) Risk Management For further examples of data elements see Annex B. When an issue is identified in one of the data sources, it is also important that the manufacturer identify and review related information from other data sources across the organization. Furthermore a review of information from external data sources should also be considered. The aggregation of information from more than the original data source may lead to more comprehensive knowledge. With this knowledge base a manufacturer will be positioned to better determine appropriate action. Phase II: Measurement and Analysis within and across Data Sources Once data sources, data elements and acceptance criteria have been specified, as part of the planning process, the manufacturer is required to perform measurement, monitoring and analysis processes to determine conformity or nonconformity. Software used in measurement, monitoring and analysis, whether purchased (Off-The-Shelf) or custom developed, should be validated for its intended use. For example, a customer survey conducted by the marketing department, indicated that there was a general dissatisfaction with the packaging of product X. When investigated further (within and across other data sources) and reviewed with other data from complaints, returned product and service reports, it became evident that there was a potential for misuse, unsafe use, or damage to the device as a result of the current packaging design. As the result of this analysis, escalation to Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0) for preventive action may be appropriate. Measure For the purpose of this guidance, measurement is a set of operations to determine a value of a data element (i.e. quantity, quality). Data collected from the measurement of product, process and QMS are acquired throughout the life-cycle of the product. The manufacturer should define for example frequency of the measurement, precision and accuracy of the data. The manufacturer should also ensure that the data collected is current and relevant. Measurement data should be retained as a quality record. The manufacturer should maintain the data in a form that is retrievable, suitable for analysis and meets both QMS and regulatory requirements. Monitoring is the systematic and regular collection of a measurement. The manufacturer should define during the planning phase what, when and how data should be monitored. The data should be defined such that it can be analyzed for further action. The monitoring of data may be continuous or periodic, depending on the type of data source and elements. The monitoring processes should be periodically reviewed for their continued suitability. Analyze For the purpose of this guidance, analysis is a systematic review and evaluation of data from measurements to derive a conclusion. The manufacturer should have documented procedures for the analysis of data against the established criteria (see 4.1). Analysis is performed to identify nonconformity or potential nonconformity or identify areas where further investigation should be initiated. In addition analysis is used to demonstrate the suitability and effectiveness of product, process and QMS. Analysis can be performed utilizing analytical tools, a team of experts, process owners or independent reviewers. The results of the analysis should be documented. After it is determined what will be measured, statistical techniques should be identified to help understand variability and thereby help the manufacturer to maintain or improve effectiveness and efficiency. These techniques also facilitate better use of available data to assist in decision making. Statistical techniques assist in identifying, measuring, analyzing, interpreting and modeling variability. For the analysis of nonconformity, appropriate statistical and non-statistical techniques can be applied. Examples for statistical techniques are: Statistical Process Control (SPC) charts Pareto analysis Data trending Linear and non-linear regression analysis Experimental design (DOE Design of Experiments) and analysis of variance Graphical methods (histograms, scatter plots, etc.) Non-statistical techniques are for example: Management reviews Results from quality meetings Safety committees (internal/external) Failure Mode and Effect Analysis (FMEA) Fault Tree Analysis (FTA) Analysis will likely occur at several different points (time and/or organizational level). For example, a certain amount of analysis and possible failure investigation (where there is evidence of a nonconformity) will occur for each data source. In addition to the analysis within the data sources there should also be a level of analysis across data sources to determine the extent and significance of nonconformity or potential nonconformity. The linkage of data from different data sources will be referred to as horizontal analysis. The horizontal analysis may: determine that the action proposed from the data source analysis is appropriate without further progress into Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0); or, provide additional information warranting progress into Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0), regardless of whether the data source analysis escalated the nonconformity or potential nonconformity. The outcome of measurement and analysis leads to different scenarios as shown in Figure 2.  EMBED Visio.Drawing.11  Figure 2: Outcomes of measurement and analysis The following tables provide more details to support the use of Figure 2. Each scenario is described with an example showing the different outcome of measurement and analysis. Basic Example The documentation requirements in a research design and development procedure were not followed. The missing documentation involves changing to a different supplier of an electronic board. The requirement is to document the supplier name and supplier number in the research report.  Scenario ANo correction required, continue measurement and monitoring The decision is made not to take any correction nor escalate the handling of the nonconformity to Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0). Example Nonconformity The supplier number was not included in the research report. (however, the supplier name is documented). Key Results of Measurement and Analysis Analysis indicates that the procedure is adequate and well known to the users of the research procedure. Following a review of the issue this appears to be a one time oversight. The intent of the requirement is for convenience only. Conclusion No initial correction - It is not necessary to update the research report, as the supplier is documented by name, hence traceability is maintained. Do not escalate to Phase III.  Scenario BCorrection required, continue measurement and monitoring The decision is made to perform a correction but not to escalate the handling of the nonconformity to Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0). Example Nonconformity The supplier name and number was not included in the research report. Key Results of Measurement and Analysis Analysis indicates that the procedure is adequate and well known to the users of the research procedure. Following a review of the issue this appears to be a one time oversight. The intent of the requirement is to ensure traceability to the supplier and this could be lost if the research report is not updated. Conclusion Take an initial correction to update the research report with the supplier name and number. Do not escalate to Phase III.  Scenario CCorrection and escalation to further investigation under the improvement phase. The decision is made to perform an initial correction. However, there is a need for escalation to Phase III (see 6.0) to further investigate as a result of the analysis performed in order to determine the appropriate corrective action.Example Nonconformity The supplier name and number was not included in the research report. Key Results of Measurement and Analysis Analysis indicates that the procedure may not be adequate and it is not well know to the users of the research procedure. The issue has been identified in multiple reports. In some cases, traceability to the supplier could be established via other means, and in other cases it could not. Conclusion Take an initial correction to update the research report with the supplier name and number (in the cases where the supplier could be identified). Escalate to Phase III for corrective action.  Scenario DEscalation for further investigation under the improvement phase. The decision is made that there is not enough information at this time to determine the required action. Therefore the investigation is escalated to Phase III. Example Nonconformity The supplier name and number was not included in the research report. Key Results of Measurement and Analysis Analysis indicates that the procedure may not be adequate and it is not well know to the users of the research procedure. The issue has been identified in multiple reports. Traceability to the supplier could not be established via other means in any of the cases. Conclusion No initial correction - The supplier is not known so an initial correction cannot be taken at this time. Escalate to Phase III for corrective action.  Documented procedures should clearly delineate and define when escalation to Phase III is required. Typically manufacturers have organizational groups or processes surrounding some of their main data sources (e.g. complaint handling, handling of nonconformities, material review boards, change management process). Within these groups or processes certain activities described in Figure 2 can be implemented without escalation. There may be predefined events that due to the significance of the risk will be escalated to Phase III without any delay that can not be justified. In the event a potential nonconformity is identified, it may be escalated into Phase III (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0) for consideration of actions to prevent the occurrence of the potential nonconformity. When no correction or only corrections within these groups or processes are taken, there needs to be data source monitoring and analysis (e.g. trending) to determine if escalation to Phase III may be necessary from accumulated information. Whenever an issue is escalated to Phase III, any information gained within the defined activities of these groups or processes should be an input to the Phase III activities such as Investigation (see  REF _Ref241462777 \r \h \* MERGEFORMAT 6.1) or Identified Actions (see  REF _Ref241462753 \r \h \* MERGEFORMAT 6.3). Phase III: Improvement The improvement phase of a corrective action process or preventive action process is designed to eliminate or mitigate a nonconformity or potential nonconformity. The improvement activities are dependant on the specific nonconformity or potential nonconformity. Any previous data from Phase II should be utilized as input to the Phase III process. The improvement phase and the activities described in Figure 3 needs to be documented. Improvement generally involves the following activities that the manufacturer would take sequentially or sometimes simultaneously: A thorough investigation of the reported nonconformity An in-depth root cause analysis Identification of appropriate actions Verification of identified actions Implementation of actions Effectiveness check of implemented actions  CONTROL Picture 4  Figure 3: Phase III Improvement Investigate The purpose of investigation is to determine the root cause of existing or potential non conformities, whenever possible, and to provide recommendations of solutions. The magnitude/scope of the investigation should be commensurate with the determined risk of the nonconformity. Good practice shows that a documented plan should be in place prior to conducting the investigation (see Annex D for examples). The plan should include: Description of the nonconformity expressed as a problem statement Scope of the investigation Investigation team and their responsibilities Description of activities to be performed Resources Methods and tools Timeframe From the information obtained throughout the process the problem statement should be reviewed and refined as appropriate. The investigation should: Determine the extent of the nonconformity or potential nonconformity Acknowledge that there are likely to be several causes of an event; hence, the investigation should not cease prematurely Require that symptoms be distinguished from root causes and advocate the treatment of root causes rather than just the symptoms Require that an end point be defined for the investigation. An overly exhaustive investigation may unduly delay the correction of non-conformity or unnecessarily incur additional cost. (For example, if removal of the causes identified so far will correct 80% of the effects then it is likely that the significant causes have been identified (Pareto rule)) Take into account the output of relevant risk management activities Agree on the form of evidence. For example, evidence should support: the seriousness of the event the likelihood of occurrence of the event the significance of the consequences flowing from the event The investigation should include the collection of data to facilitate analysis and should build upon any analysis, evaluation and investigation that were previously performed (see  REF _Ref241471920 \r \h \* MERGEFORMAT 5.0). This will require the investigator to identify, define and further document the observed effects/non-conformity, or already determined causes, to ensure that the investigator understands the context and extent of the investigation. It may be necessary to: Review and clarify the information provided Review any additional information available from an horizontal analysis Consider whether this is a systemic issue/non-systemic issue Gather additional evidence, if required Interview process owners/operators or other parties involved Review documents Inspect facilities, or the environment of the event Previous investigations should be reviewed in order to determine if the event is a new problem or the recurrence of a previous problem where, for example, an ineffective solution was implemented. The following questions will assist in making the determination: Is the nonconformity from a single data source? Does the current nonconformity correlate with nonconformities from other data sources? Are multiple data sources identifying the same nonconformity? Do other nonconformities have an effect on the problem investigated here? Many of the tools used in investigations rely upon a cause and effect relationship between an event and a symptom of that event. To ensure that causes are identified, not symptoms, the following should be considered: There must be a clear description of a cause and its effect. The link between the cause and the undesirable outcome needs to be described. Each description of a cause must also describe the combined conditions that contribute to the undesired effect A failure to act is only considered a cause if there was a pre-existing requirement to act. The requirement to act may arise from a procedure, or may also arise from regulations, standards or guidelines for practice, or other reasonably expected actions. Some of the more common tools and techniques include: Cause and effect diagrams 5 Whys analysis Pareto charting Fishbone/Ishikawa cause and effect diagrams Change analysis Risk analysis techniques Is/Is Not The outcome of an investigation should include: Clearly defined problem statement What information was gathered, reviewed and/or evaluated Results of the reviews/evaluations of the information Identification of cause(s) or contributing factors Solutions to address the cause(s) or contributing factor(s) Identify Root Cause Causes or contributing factors of detected nonconformity or potential nonconformity should promptly be identified so that corrective action can be taken to prevent recurrence, or preventive action taken to prevent occurrence. The process to identify the root cause should start with the output(s) of the investigation (see  REF _Ref241463272 \r \h \* MERGEFORMAT 6.1). When assessing relevant data, the following should be considered: Systematic generation of cause and effect conclusions supported by documented evidence Evaluate significant or underlying causes and their relationship to the problem Ensure that causes are identified, not the symptoms Check for more than one root cause (above processes if necessary) Causes or contributing factors of nonconformities or potential nonconformities may include the following: Failure of, or malfunction of, incoming materials, processes, tools, equipment or facilities in which products are processed, stored or handled, including the equipment and systems therein Inadequate or non-existent procedures and documentation Non-compliance with procedures Inadequate process control Inadequate scheduling Lack of training Inadequate working conditions Inadequate resources (human or material) (Inherent) process variability For further details on aspects to be considered when doing the root cause analysis see Annex C. The output of the root cause analysis should be a clear statement of the most fundamental cause(s) resulting in the nonconformity (see Annex D for examples). Identify Actions When the root cause(s) has been determined, the manufacturer should identify and document the necessary corrections and/or corrective actions or preventive actions. These actions should be reviewed to ensure that all necessary actions are identified. The review may benefit from a cross functional approach. Where applicable, product disposition decisions should also be documented. The following outcomes are possible and should be documented: No further action necessary (provided that no safety issue exists and regulatory requirements are met) With continuous monitoring Acceptance under concession and continuance of monitoring Correction It may be necessary to take initial corrections (e.g. containment, stop of shipment/supply, issuance of advisory notice) in order to address an immediate risk or safety issue. This may be necessary before investigation has been completed and root cause has been determined. However, after investigation and root cause determination, additional and/or possibly different corrections may become necessary. Corrective action Corrective action should address systemic problems. For example, changing the procedure and training of personnel to the revised procedure may not, by itself, be appropriate or sufficient to address the systemic cause(s). Preventive action By its very nature preventive action can not follow a nonconformity. As a result of this step, a list of action items should be documented. These may include: A detailed description of the implementation Review regulatory requirements (e.g. submissions, licensing, certifications) Roles and responsibilities for execution of action items Identification of the necessary resources (e.g. IT, infrastructure, work environment) Verification and/or validation protocols of the action(s) with acceptance criteria Implementation schedule, including timelines Method or data for the determination of effectiveness with acceptance criteria Identify the starting point of monitoring, and end point of correction and/or corrective action or preventive action as described above Verify Identified Actions Before the implementation of action(s), a manufacturer should verify the identified action(s) and approve their implementation. In addition validation may be required where process validation or re-validation may be necessary, or where user needs or intended uses are changed and design validation will be required. Verification activities are to ensure that all the elements of the proposed action (documentation, training etc) will satisfy the requirements of the proposed action. These activities should be performed by persons who are knowledgeable in the design or use of the product or process that is the subject of corrective or preventive action. Verification of a preventive action can be accomplished by introducing the conditions that would induce a nonconformity and confirming that the nonconformity does not occur. Validation activities generate data and information that confirm the likelihood of the effectiveness of the corrective action to eliminate the nonconformity or proposed nonconformity. Examples of items to be considered when planning the verification/validation activities include: Does the action(s) eliminate the identified root cause(s)? Does the action(s) cover all affected products/processes? Does the action(s) adversely affect the final products? Is it possible to finalize the actions timely in planned schedule (resources, materials/kits, logistics, communications, etc.)? Is the execution of the action commensurate with the degree of risk previously established? Are new risks or nonconformities derived from the action? Implement Actions The following items that may be considered at implementation should be documented: Parties involved Materials Processes Training Communications Tools Timelines for the implementation of the approved action Verify that the implementation has been completed. Determine Effectiveness of Implemented Actions The manufacturer should gather data over a period of time related to the effectiveness of the implemented action (see Annex D for examples). Management should ensure and be involved in a review and confirmation that actions taken were effective and did not introduce new issues or concerns. The following questions should be considered at appropriate times throughout the process and be revisited in the final review: Has the problem been comprehensively identified? Has the extent of the problem been identified (e.g. range of affected devices, patient outcome, process, production lines, operator)? Have the root cause/contributing factors of the problem been identified and addressed? Has the improvement action(s) been defined, planned, documented, verified and implemented? If the manufacturer finds the actions are not effective, the manufacturer should re-initiate Phase III activities (see  REF _Ref241464087 \r \h \* MERGEFORMAT 6.0). If the manufacturer finds the actions create a new issue or a new nonconformity then the manufacturer needs to initiate Phase II (see  REF _Ref241464109 \r \h \* MERGEFORMAT 5.0) activities. Phase IV: Input to Management Management at different levels in the organization should be involved in each improvement action either through approval of the improvement steps or reporting. The Management Review is the overall mechanism for management to ensure that the Quality Management System as a whole is effective. Report to Management The manufacturer should have a mechanism/procedure that expeditiously raises safety related issues or other high risk issues to management. These issues can be identified in the data sources, the improvement phase (see  REF _Ref223375282 \r \h \* MERGEFORMAT 6.0), or originate from other sources external to the Quality Management System. In addition to this expeditious escalation mechanism, the manufacturer should define management and personnel responsibilities (i.e. process owner) for the measurement, analysis and improvement processes, to ensure that the processes and the actions being implemented are effective. For this purpose there needs to be a mechanism for management at different levels to stay informed of the information or data from: The measurement and analysis activities from the individual data sources The investigations, actions, implementations, etc. from the improvement processes Management Review The manufacturer has procedures for what is provided as input for the management review, including relevant information from the improvement processes, such as improvement actions (corrective actions, and/or preventive actions) as well as important corrections. The manufacturer needs to define what meaningful data is to be reported for a management review. Data should be specific to the quality objectives of the manufacturer and be reported regularly. Merely providing the number of improvement actions or the number of how many improvement actions are opened or closed to the management review process are not sufficient in assessing the effectiveness of the processes. Included in this review would be an assessment of any opportunities for improvement of the device, manufacturing process, QMS or the organization itself. An outcome of the review could be the allocation of funding or personnel to a particular area, project or device that the review has identified as not meeting customer and regulatory safety and effectiveness expectations. Annex A: Examples of Phase Activities List of possible activities corresponding to the phases in Figure 1. The following is an outline/aid memoir of the main points described in this document. It is not intended as a box ticking exercise and should not be used as such, but used purely to summarize and align the steps in the process described in this document. The activity numbers do not imply sequential steps some steps may take place in parallel. The references in this Annex refer to the sections in this document. PhaseActivitiesPlanning Identify all data sources (internal/external) by product type (4.1) Identify resources required and individual personnel responsibilities for measuring each data source (4.1) Define the requirements for each data source and the data elements within each data source that will be measured and analysed (4.1) Define requirements for escalation to the improvement phase (4.1) Define requirements for monitoring the measurements in the data sources (5.1) Establish data sources (4.2) Measurement and Analysis within and across Data SourcesMeasure and analyse all data sources for nonconformities and potential nonconformities (5.0, 5.1 and 5.2) Have reports of nonconformity or potential nonconformity come from more than one data source? Is the nonconformity or potential nonconformity systemic? ImprovementDetermine scope and required outcome of investigation (6.1) Investigate nonconformity or potential nonconformity (6.1) Analyse nonconformity or potential nonconformity for root cause(s) (6.2) Identify actions ( correction, corrective action or preventive action) (6.3) Verify proposed actions before implementation (6.4) Implement proposed actions (6.5) Determine effectiveness of actions (validate if possible) (6.6) Input to ManagementReport investigation and outcome to management (7.1) Review investigation, analysis and outcome (6.6, 7.2) If not satisfied return to step 10 If required, report to regulator (note: reporting may be required earlier depending on severity)* Audit system at determined intervals* If numbers of nonconformities or potential nonconformities exceeds targets, review all QMS processes*  *Steps 20 to 22 are not described in this document but are added as reminders of general management responsibilities in this area of the QMS. Annex B: Examples of Data Sources and Data Elements Examples of data sources and their data elements can be, but are not restricted to: Data SourcesData Elements Regulatory RequirementsResult of a regulatory inspection New or revised regulatory requirementsManagement ReviewManagement review outputSupplier Performance/ControlsNumber of batches received Batch and/or shipment Inspection and test records Quantity of rejects or deviations Reason for rejection By supplier, if more than one supplier Use in which product or service Supplier problemsComplaint Handling Quantity By product family By customer (physician, healthcare facility, patient, etc.) Reason for complaint Complaint codes Severity Component involvedAdverse Event ReportingEvent Quantity By product family By customer (physician, healthcare facility, patient, etc.) Type of event (death or serious injury, etc.) Component involvedProcess ControlsBy product Operator Work shift Equipment and/or instruments used Inspection and test records In-process control results Process control parameters Inspection process Final acceptance Rejects Special process Validation study results Process monitoring observationsFinished ProductInspection and test recordsQuality Audits (internal/external)Observations (number, category, corporate policy, regulatory requirements, significance, etc.) Repeat observations (indicative of effectiveness) Closure times Overall acceptability of contractor or supplier Compliance to audit schedule Audit personnelData SourcesData Elements Product RecallTimeliness of recall communication Classification of recall Recall effectiveness checksSpare Parts Usage Frequency of replacement Batch number of spare part By supplier of spare part, if more than one supplier By customer By location or area of customerService ReportsInstallation First use of equipment Frequency of maintenance visits Types of repairs Frequency of repairs Usage frequency Parts replaced Service personnelReturned ProductQuantity Reason for returning product By customer Types of defects identified on returned productMarket/Customer Surveys Customer preferences Customer service response time Solicited information on new or modified productsScientific LiteratureResearch papersMedia SourcesArticles in trade journals Product Realization ( Design, Purchasing, Production and Service and Customer information) Design and development review results Design and development verification results Design and development validation results Design and development changes (reason or cause for change, effectiveness of change, etc.) Controls on purchased products or services (See above Supplier Performance/Controls) Verification results of purchased product Inspection and testing data of purchased product Production and Service processes- Cleaning operations of product and facilities Sterilization Installation results Servicing and Maintenance if required (See also: Service Reports) Verification and Validation results of processes used in production and service. Including approval of equipment and qualification of personnel Traceability Data Controls of monitoring and measuring devices Calibration and maintenance of equipment Customer Information- New or repeat customer Customer feedback maybe in other forms than complaints or returned product (Customer Service call data, repeat sales , delivery/distribution data)Risk Management Published reports/literature of failures of similar products Stakeholder concerns and generally accepted state of the art Risk acceptability criteria Annex C: Examples of Contributing Factors Examples of possible contributing factors to be considered when doing the root cause analysis: Materials Defective raw material (does material meet specification?) Batch related problem Design problem (wrong material for product, wrong specifications) Supplier problem (lack of control at supplier, alternative supplier) Lack of raw material. Machine / Equipment Incorrect tool selection suitability Inadequate maintenance or design calibration? Equipment used as intended by the manufacturer? Defective equipment or tool End of life? Human error inadequate training? Environment Orderly workplace Properly controlled temperature, humidity, pressure, cleanliness Job design/layout of work Management Inadequate management involvement Stress demands Human factors Hazards not properly guarded Were management informed / did they take action? Methods Procedures not adequately defined Practice does not follow prescribed methodology Poor communications Management system Training or education lacking Poor employee involvement Poor recognition of hazard Previous hazards not eliminated Measurement, monitoring and improvement Inadequate measuring and improvement Annex D: Examples for Documentation of the Improvement Processes The table below includes guidance for documenting various requirements of the improvement processes. GuidanceExample DocumentationProblem StatementClearly defined problem statement. State how the issue was discovered. The process/procedure that was not followed. Provide evidence What, When, Who, Where and How much (as applicable) During in-process testing of Product A finished product on [date], two devices out of 30 were found to be nonconforming per Design Document 123456, revision A. Note 2.1 in Design Document 123456 requires that the surface finish be 32 inch maximum on all exterior surfaces. The two nonconforming devices had a surface finish above the maximum 32 inch finish as follows: Serial Number 54321 had a surface finish of 67 inch Serial Number 65432 had a surface finish of up to 38 inch CorrectionGeneral Examples Containment, Stop of shipment/ supply Issuance of advisory notice Incident awareness / training Change or suspend production processThe supplier was notified of the issue on [date]. The supplier conducted an operator awareness training of the incident on [date]. Initial extent of the issue is restricted to supplier lot #678. All unused components and product built with components from this lot were controlled on [date]. No product built with this lot had been distributed. InvestigateClearly defined problem statement (update/refine if new information is determined) What information was gathered, reviewed and/or evaluated Results of the reviews/evaluations of the information Identification of cause(s) or contributing factors See initial problem statement. Subsequent investigation confirmed that the issue was limited to lot #678. All additional available lots of this component were inspected with a 95/95 inspection plan and no additional lots were confirmed to have the issue. The incoming inspection process and component FMEA were reviewed and determined to be adequate and accurate, respectively. Review of finished product reject data over the past year revealed no other rejects for surface finish of this component. The following problem-solving tools and methods were used during the course of the investigation of the surface finish issue. Fishbone analysis see the attached file labeled Surface Finish Analysis. Conference calls and documentation reviews with the Supplier see attached file which contains the minutes from the conference calls. Results of the investigation were the following. Two different raw tubing lots were mixed at the Suppliers finishing process. One raw tubing lot was intended for customer As products (Lot number 10000-100 requiring a surface finish of 32 inch maximum) and the other was intended for customer Bs product which had a surface finish above the 32 inch maximum.Identify Root CauseThe output of the root cause analysis should be a clear statement of the most fundamental cause(s) resulting in the nonconformity It has been concluded that the root cause of the tubing surface finish issue is inadequate line clearance procedures established at the supplier.Planned actionsSpecify: What the action is Who will do it When it should be doneCorrective action: Supplier to add line clearance requirements to documented procedures by [date]. Preventive action: Not applicable. Verification of actionsVerification activities are to ensure that all the elements of the proposed action (documentation, training etc) will satisfy the requirements of the proposed action Validation activities generate data and information that confirm the likelihood of the effectiveness of the corrective action to eliminate the nonconformity or proposed nonconformity.General examples are included below. Actual documentation would need to be more specific. Review and approval of the procedural changes prior to use Conduct a pilot of new procedure on a specific project/department/time frame prior to full scale implementation Verification that the updated supplier procedure addresses the process that caused the nonconformity Verification that the training materials address the specific process that caused the nonconformity Comparing a new design specification with a similar proven design specification Performing calculations using an alternative method Perform validation of equipment, software, production processes, test method, component, etc. Specific example: Review and approval of supplier procedure XXX by the supplier and the customer to ensure adequacy of the updated line clearance process. Verification of effectiveness Method or data for the determination of effectiveness with acceptance criteria. The improvement goal The evidence (data sources) that will be used to support effectiveness (e.g., a data source could be where the problem was initially found) The time frame that effectiveness will be monitored (e.g., upon completion of actions or three months, six months as appropriate) OR Sample size required to demonstrate effectiveness X months after implementation: Conduct a query of the electronic manufacturing data system to verify there are zero surface finish rejects for this component at finished Product A final inspection. Supplier Quality Engineer to conduct on site review at the supplier of the action to confirm the procedures are in place, are known to the operators, and there is evidence that the procedures are being followed. Winterhufen 1.0  Japanese Ministry of Health Labor and Welfare  US Food and Drug Administration     Guidance on corrective action and preventive action and related QMS processes GHTF/SG3/N18:2010 November 4, 2010Page  PAGE 26 of  NUMPAGES 26   #+,MN᠎p_Np?0hdCh2P5B*CJ phhdCh5B*CJ ph hh,95B*CJ,aJ,ph hh&5B*CJ,aJ,ph hh5B*CJ,aJ,phhdChB*CJph"jhn7hn7B*CJUph!hdChB*CJmHphsH hdChsie5B*mHphsHhBNK5B*mHphsH hdCh"5B*mHphsH hdCh5B*mHphsHh5B*mHphsH,MP   %^%`gda gd gda Hdhgd$ Hdha$gd$a$gdgd$a$gd$a$gd\NOPQXs       4 5 6 7  ǸǐǸumaRhhCJOJQJaJhaCJOJQJaJhaCJaJh'haCJaJhpCJaJhphahdChB*CJphhB*CJ\phhdCh3]B*CJ\phhdChB*CJ\phhdCh5B*CJphhdCh_",5B*CJphhdCh5B*CJ phha5B*CJ ph  5 6 7      ' (  l _ $ `$a$gd\gd %^%`gda      ' ( ) @ A B ^ _ f g h ĵxmxeaeSH9Hjhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7jhn7UhdChWEB*phjhdChn7B*UphhdCh5B*CJphhdChB*CJaJphhdCh lB*CJaJphhhB*CJaJphhh5CJaJhhCJOJQJaJhhCJOJQJaJ"hh6CJOJQJ]aJ         : ; > ? J K L f ˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#j<hn7UmHnHu#j;hn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j ;hn7UmHnHu+f g h i j k l m     ,-01=>?Y˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#j}=hn7UmHnHu#j=hn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j<hn7UmHnHu-YZ[\]^_`|} #$123M˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#j>hn7UmHnHu#jw>hn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j=hn7UmHnHu-MNOPQRSTpqtu7˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jk@hn7UmHnHu#j?hn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#jq?hn7UmHnHu-S=uG>It#gN3gdWE ! $ 789:;<=>Z[^_pqr     +,/0STUo˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jAhn7UmHnHu#jeAhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j@hn7UmHnHu-opqrstuv$%&@ABDEFGHdehipqr˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jYChn7UmHnHu#jBhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j_Bhn7UmHnHu-  789;<=>?[\_`stu˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jDhn7UmHnHu#jSDhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#jChn7UmHnHu-   &'(BCDFGHIJfgjk|}~˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jGFhn7UmHnHu#jEhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#jMEhn7UmHnHu-   /034QRSmnoqrstu˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#jGhn7UmHnHu#jAGhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#jFhn7UmHnHu- !"#$@Afgh˸˴˦ޛ˸˴˦ޛw˸˴˦ޛ#j5Ihn7UmHnHu#jHhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#j;Hhn7UmHnHu)DEF`abdefgh˸˴˦ޛ˸˴˦ޛw˸cXhdChB*ph&jhdChn7B*CJUaJph#jJhn7UmHnHu#j/Jhn7UmHnHuh=YmHnHuhh=Y0JmHnHuhn7%h=YCJPJ_HaJmHnHtHujhn7UhpmHnHujhn7UmHnHu#jIhn7UmHnHu"[\ dfgjnͱ~i^S^HSHShdChyzB*phhdCh_B*phhdChJB*ph)hdCh~XB*CJ_HaJnHphtHhdChrB*ph)hdCh<B*CJ_HaJnHphtH%hdCh<B*NH_HnHphtH!hdCh<B*_HnHphtHhdCh<B*phhdCh7B*ph hQhhQB*phhdChB*phhdChB*NHphNOY Z !!!!2#3#S$T$$$$%%%4&gd G<^<gd{Egd7 7$8$H$gd~X3gdQ  8;_ABNOV麨ti^^SKh+;B*phhdCh&B*phhdChDB*phhdCh{EB*phhdCh75B*phhdCh]B*NH\phhdCh]B*\phhdCh]B*ph"jhdChN0JB*UphhdCh7B*phhdCh5B*phhdCh9h"B*phhdCh9B*phhdCh_B*phhdChyzB*phVYemw~      ' . ; I V W Y Z [ Ƚ޽ӽ޽޲ޒ|q|qfq[hdChB*phhdCh2B*phhdCh_ B*phhdCh6 AB*phhdChCjB*phhdChJB*phhSB*phhAh7B*NHphhAh7B*phhdChDB*phhdCh+2B*phhdChhB*phhdCh7B*phhdCh&bB*phhdCh+;B*ph! !!!!!!K!!!!!!""""""##/#0#1#3#p#v###R$T$ķĨĝrg\\QhdChJB*phhdChHcB*phhdCh GB*phhdChCjB*NHphhdChQB*phhdCh+2B*phh+;B*phhdChCjB*phhdChCjB*NH\phhdCh GB*\phhdChCjB*\phhdCh_ B*phhdChB*NHphhdChB*phhdCh`B*phT$$$$$$$a%i%%%%%%%%%,&-&4&5&?&A&u&z&ȽzododQ$hdCh-B*PJ]nHphtHhdCh-B*phhdCh;B*phhdCh}HnB*ph(hdChGB*CJOJQJ]^JphhdCheq)B*phhdCh7B*NHphhdCh{EB*phhdCh7B*phhdChB*phhdChJB*phhdCh GB*phhdChHcB*phhdChCjB*ph4&@&u&&'!'''5(((3)>))))*O***+gd:mgd:m7^7gdQgd] ^`gdQ ^`gd] 7^7gd] gd;z&|&&&&&& ''''"'_'`'c'k'{'|'''''''''( ( ((;(<((ڴ{hS(hdCh-B*NHPJ]nHphtH$hdChB*PJ]nHphtHhdCh-B*NHphhdCh&bB*phhdCh}HnB*phhdCh-B*phhdCh;B*ph$hQh-B*PJ]nHphtH$hdCh&bB*PJ]nHphtH$hdCh-B*PJ]nHphtH$hdCh\xB*PJ]nHphtH (((((((((((()))2)3)))))))))))) ****ⶫ⏄yylyahQh5B*phhdCh-B*NHphhdCh-B*phhdCh;B*ph!hdCh5B*CJmH phsH hdCh;B*phhdCh:mB*phhdCh]nEB*phhdChjB*phhdCh0B*phhdChsB*phhdCh]B*ph$hQh5B*PJ]nHphtH****A*N*O*S*T*U*V***************ڴvgg\Q\QFQhdCh&bB*phhdCh-B*phhdCh;B*phhdCh5B*mH phsH !hdCh-B*NHmH phsH hdCh] B*mH phsH hdCh-B*mH phsH hdChB*mH phsH $hdCh&bB*PJ]nHphtH$hdCh] B*PJ]nHphtH$hdCh-B*PJ]nHphtH$hdChB*PJ]nHphtH*+C+K+f+n++++++++++,,,,*,,,,,,,,,,,,t_(hdCh3B*NHPJ]nHphtH$hdCh5vB*PJ]nHphtH$hdCh&bB*PJ]nHphtH$hdCh] B*PJ]nHphtH$hdCh3B*PJ]nHphtH$hdChB*PJ]nHphtHhQh}HnB*phhdChZAB*phhdCh3B*phhQh-B*ph++++,*,,,--..&...//gd   1$7$8$H$gd@_gdV&gd)kgdz4@ ^`gdQ   ^ `gdQ   ^ `gd]  ^`gd] 7^7gdQgd3,,,,,,1-9----------...%.&.ڴڀmYNChdCh)kB*phhdCh23B*ph'hdChQ5B*PJ]nHphtH$hQhX B*PJ]nHphtH$hdChB*PJ]nHphtHhQh5B*phhdChxwB*phhdCh3B*ph$hQhDUB*PJ]nHphtH$hdCh4DB*PJ]nHphtH$hdCh3B*PJ]nHphtH$hdCh\xB*PJ]nHphtH&....//=/>/?/B/C/D///////////00%0Ǽ˴˩ncXcXcMBhdChQ oB*phhdCh~qB*phhdChoB*phhdCh`B*ph$hdCh'B*PJ]nHphtH(hdChl"B*NHPJ]nHphtH$hdChl"B*PJ]nHphtHhdCh5B*phhpB*phj)Khn7Uhn7jhn7UhdChl"B*phhdCh6WB*phhdChV&B*phhdCh@_B*ph%0&020R0S0U0v000000000011 1!1"1A11111ܹܮܔ܉ܹ|odYLhdChf+B*\phhdChtB*phhdChl"B*phhdCh55B*phhdChQ o5B*phhdCh5B*phhdCh~q5B*phhdCh'B*NHphhdCh'B*phhdCh`B*phhdCh5B*phhdChX B*phhdCh~qB*phhdChQ oB*phhdChQ oB*NHph/T0U0!1"122556677889999$a$gd!gdyy  1$7$8$H$gd5  1$7$8$H$gd gd gdERgdjgde]  1$7$8$H$gd  1$7$8$H$gd`1111122222 33i3w3+4;4>4E4L4M4N4O4_4a44455w5x5666лаsh]hdCh<+dB*phhdCh+B*phhdChe]B*NH\phhdChe]B*\phhdCh4B*phhdChe]B*phhdCh&ZB*phhdChQB*phhdCh`B*NHphh5 B*phhdCh`B*phhdChyB*phhdCh?`B*\phhdCh`B*\ph 66778797|777777777777788?88888ƹ鮣zodoWLhdChRB*phhdCh 6B*phhdCh$B*phhdCh B*phhdChSB*phhdCh4B*phh4B*phh-EhERB*phhdChERB*phhdChx6B*phhdCh@H B*NHphhdCh@H B*phhdCh<+dB*NHphhdChu+B*phhdCh<+dB*phhdCh B*ph8=9>9A9B9999999999999999·~ncXMcB7hdCh\B*phhdChA B*phhdCh=B*phhdCh!B*phhdCh4qB*phjKhdChQB*Uph$j3S hdChQB*UVphhdChQB*phjhdChQB*UphhdCh[*B*phhdChsB*phhdCh B*phhdCh5B*NHphhdCh5B*phhdCh5B*PJphhdChRB*PJph9995;6;k<l<m<n<<|>}>??@@AAA  1$7$8$H$gdc=M  1$7$8$H$gdfgdf  1$7$8$H$gdSgdJG  1$7$8$H$gd\gdV&gd&gd\gdA 999:%:]:^:d::::::; ;;;;;;;;;;;K<L<k<l<n<<ӻӥӚӚӏӏӏӂufu[NhdChJGB*CJphhdCh2B*phhdCh&B*NH\phhdCh&B*\phhdCh&5B*phhdChB*phhdChK8B*phhdCh)9!B*phhdChB*phhdCh`B*phhdChV&B*NHphhdCh&B*phhdChV&B*phhdCh\B*phhdChJGB*ph<<<<<F=K=>>{>|>}>>>?&?(?,?C?D?z?{????????@!@"@@Ƚuh]RhdCh&B*phhdChnNB*phhdChfB*NHphhdChN5B*phhdChNB*\phhdChgdB*\phhdChfB*phhdCheJeB*phhdCh; !B*phhdChSB*phhdCh^0B*phhdChi B*phhdCh7B*phhdChHB*phhdCh\B*ph @@@@mAnAAAAAAAAAAAA$B&B,B0B1B5BHBwBBBBBBBBCCCC$C7CGgGhGiGlGmGoGGGƹƮƮvnchdChB*phhpB*phjhn7Uhn7jhn7UhdChLB*phhdCh%OB*phhdChbZB*phhdCh7SB*phhdChp|B*NHphhdChp|B*phhdCh!Z:B*phhdChB*NHphhdChB*phhdCh7B*ph!GGGjHHHHHHHHHHHIII%I:I;I=IIIYJZJJKKLLfLٿ󿵞ن{naVhdCh1B*phhdChPB*CJphhdChF:B*CJphhdCh7SB*phhdChmB*phhdCh5B*phhDr}B*\phhdCh^B'B*\phh5 B*\phhdCh/B*\phhdChB*NHphhdChB*phhdChB*NH\phhdChB*\phfLkLLLLGMHMIMMMMMMMMMMMMMM,N-N4N5N6N=NNNNNNNNNNNNNNNO OĹĂčĂwĂwĮlĮĂĂĂĂĂhdChrqDB*phhdChJB*phhdChF:B*phhdChB*phhdChK5B*phhdCh$B*phhdChl:)B*phhdChrcOB*phhdCh~$B*phhdCh15B*phhdCh(yB*NHphhdCh1B*phhdCh(yB*ph*LHMIMMMMMMM NN?NNN`NpNNNNNO(O & F1$7$8$H$gd~$ & F1$7$8$H$gd$ & F1$7$8$H$gdrcO  1$7$8$H$gdF: 1$7$8$H$gd1  1$7$8$H$gd1 OOOOO'O(O)O-O5O>OAOFOOOSOYOZO[O\O]OOOOOOPPPxk^k^kQkQhdCh%B*\phhdCh8 aB*\phhdCh?B*\phhdCh?57B*phh-EB*phh-Eh_gB*phhdCh4B*phhdCh1B*phhdChoYB*phhdChfB*phhdChY'rB*phhdChY'rB*CJaJphh~$B*phhdCh~$B*NHphhdCh~$B*ph(O)O\O]OHQIQQ{R|RSSiUjUsUUU5W6WW  1$7$8$H$gd=gd! %gdgd4 %  1$7$8$H$gdc  1$7$8$H$gdYF gdPgdB1  1$7$8$H$gd1 1$7$8$H$gd1PP-P.P=PrPsPtPxPyPPPHQIQOQPQQQRQZQcQhQkQlQwQ}QQQQQQQʽwlwlaaaVhdChYF B*phhdCh'B*phhdCh,voB*phhdChkB*phhdChRxB*phhdChd!B*phhdChPB*phhdCh:B*phhdCh8 aB*NH\phhdCh8 aB*\phhdCh:B*\phhdCh?B*\phhdCh%B*\phhdCh%B*NH\phQQeRhRvRyRSSS S#S$S-S4S=S>SASESOS[ScSdSeStSSSJTKTaTcT U U6U7U8U;UV?VGVVVWV[V\VrVVVVVVVWWW幮zrgg\O\gg\ghdCh 3B*NHphhdCh 3B*phhdCh\B*phh%TvB*phh?>B*phhdChk5B*phhdCh 4B*phhdChkB*phhdChB*CJaJphhdCh,uB*CJaJphhdChhB*phhdCh,uB*NHphhdChsB*phhdChCB*phhdCh,uB*ph&ZZZZZZZZ[[ [ [z[[[\\%\&\*\G\N\]\_\]]]] ^Ӱwl_lTlhdCh5B*phhdChzB*NHphhdChzB*phhdChB*phhdCh$B*phhdCh\B*phhdChY B*NHphhdChY B*phhdCh B*phhdCh'B*NHphhdCh*eIB*phhdCh>>B*phhdCh- jB*phhdCh'B*phhdChB*ph ^^[^b^p^{^^^^^____3`N`O`j`l```````0a3aGaaaaa b b鼦xmmbmUhdChPzB*NHphhdCh*eIB*phhdChPzB*phhdChZB*NHphhdCh9yB*phhdChY_B*phhdChZB*phhdChuoB*phhdChF:B*phhdChzB*mHphsHhdChADB*phhdCh5 B*phh5 B*phhdChzB*phhdCh,B*ph!____ `3`N`O`HaIab@c!d"d}d~d  1$7$8$H$gdMtK  1$7$8$H$gd,< & F  1$7$8$H$gdPz  1$7$8$H$gdPz  1$7$8$H$gd & F  1$7$8$H$gd   1$7$8$H$gdz bbbb c c3c4c5c8c9c@cAcccccccccc"dNdOdSd]dgdsdvd|d}d~ddddշ韒odhdCh[B*phjhdCh[B*UphhvB*phhdChXB*phhu^hu^B*\phhu^h,<B*\phhdCh9B*phjhn7UhpB*phjhn7Uhn7jhn7Uh B*phhdChPzB*phhdCh*eIB*ph#~dddddd~eeef $IfgdBNK  1$7$8$H$gdu^  1$7$8$H$gdMtK$$$  7$8$H$a$gd[ $$8qgd[ ddddddddddee%e*e+eCe}e~eeeee,fͼyjy_PE:Eh\1h%TvB*phh\1h*RB*phh\1h*RB*CJaJphhdChvB*phhu^hu^B*NH\phhu^hu^B*phhu^hu^B*\phhu^h*RB*\phhu^hvB*phh[B*phhdCh[B*ph!hdCh[B*CJ^JaJphjhdCh[B*UphjhdCh[B*Uph$j3S hdCh[B*UVph,fKfffffffffhgiggggggggggggghhhhh.i/i0iiiiiiiiii9jӷ騠ӨzӨiӨӷ!h\1h*RB*CJNHaJphh\1h*RCJ aJ hpB*CJaJphjhn7Uhn7jhn7Uh\1h*RB*CJaJphh\1h*R5B*phh\1hvB*CJ aJ ph h\1h*Rh\1h*RB*CJ aJ phh\1h*RB*phh\1h%TvB*ph)fffff{{{ $IfgdBNK{kd$$Ifl0$h  t0644 layt\1ffffg{  $1$7$8$H$Ifgd\1 $IfgdBNKhkdw$$Ifl$h% t0644 layt\1ggggghi``UH <$Ifgd\1K$ $IfgdBNKK$ $IfgdBNKkd$$Ifl0$h   t0644 lapyt\1hhFhhh/i <$Ifgd\1K$ <$Ifgd\1 $IfgdBNKK$Ukdc$IfK$L$l044 t644 layt\1/i0i;iiii0Ukd$IfK$L$l044 t644 layt\1 <$Ifgd\1K$ <$Ifgd\1 $IfgdBNKK$Ukd$IfK$L$l044 t644 layt\1iiiiii{{kd$$Ifl0$h  t0644 layt\1 $IfgdBNKiii9jj $IfgdBNKhkd$$Ifl$h% t0644 layt\19jjjjjjjjjjjjjjj@kAkkkll'm(m)m*m+m,m.m/m0m1mB*phhdCh9[B*phhdCh[CB*phhdChlB*phhdChRrB*phh-B*phhdCh-B*phj<hn7UhpB*phjhn7Uhn7jhn7UhdCh%$B*phhdChG/B*ph$zzzz{ {{7{;{<{@{N{O{P{Q{{{{{{ | |||||"|#|*|U|t|u|||޵Ӫti^i^i^hdCh"B*phhdChU1B*phhdCh0B*phh%TvB*phhdChQ,B*phhdChRrB*NHphhdChRrB*phhdCh>B*phhdChB*phhdCh=B*phh=B*phhdCh B*phhdChB*phhdChDB*phhdChlB*ph!zz{ |+|R|u|||||||}~~~~?is & F h 1$7$8$H$^gdBNK  1$7$8$H$gdRrgdRr$a$gdgE2 & Fgd! gdRrgdD||||||||||||||||}}}}ƻƍzog\MB7BhdCh5IB*phhdChihB*phhdChRrB*CJaJphhdChM:B*phhgE2B*phhdChBB*phhM:B*phhdCh! B*phhdChgE2B*phjhn7hn7B*Uph$j3S hdChn7B*UVphhdChn7B*phjhdChn7B*UphhdCha<B*phhdChRrB*phh%TvB*phhdChrB*ph}}~~~~v~w~}~~~~~~~~~~hirs%&'1Ϸ疎烎xmxmxbxWhdChNB*phhdChf.B*phhdCh'B*phhdChRrB*phhdCh5B*phh%TvB*phhdCheB*phhdChkB*phh*hA B*phhdChA B*phhdChih&B*NHphhdChih&B*phhdChih5B*phhdChihB*phhdChihB*NHph!s 'lfʂSpփ׃ & F  1$7$8$H$gdN & F 8 81$7$8$H$^8gdBNK  1$7$8$H$gdRr  1$7$8$H$gdih & F h 1$7$8$H$^gdBNK1LklxÀĀƀFefn +,-ǂȂɂʂςJQSֳֳ֑֨ֆֳ˨֨{ֆhdCh wB*phhdChbdB*ph,hdChRr5B*CJOJQJ^JaJphhdCheB*phhdChRrB*NHphhdChZ`B*phhdChj0B*phhdChRrB*phhdChNB*phh%TvB*phhdCh4B*ph0So׃؃%*lpDž̅34=QpqxȆՆֆ݆{~ׇʿηhdChTB*phhdChj0B*phhdChNB*phhdChlB*phhpB*phjhn7Uhn7jhn7UhdChiB*phhdCh6B*phhdChRrB*phh%TvB*ph54qֆ!Q01   1$7$8$H$gd q & F  1$7$8$H$gdN & F  1$7$8$H$gdN  1$7$8$H$gdRr & F  1$7$8$H$gdN & FgdNׇ؇!$QV01=GÊ*2ANghXY[\]^fnv̌͌׌،ٌ睨煨xhdChRr5B*phhdCh75B*phhdChB*phhdChgdB*phhdCh7B*phhdCh9B*phhdCh3B*phh%TvB*phhdChlB*phhdChNB*phhdChRrB*phhdChRrB*NHph-<Vgw͌ڌ ,e΍ ؏/ & F  1$7$8$H$gdj>gdRrh^hgdip & Fgdj>gdPK & Fgdrt  1$7$8$H$gdRrٌڌ͍΍ύ &>VWqr͎ΎώҎ֎bchkløxmbhdCh B*phhdCh B*phhpB*phjchn7Uhn7jhn7UhdChZvB*phhdCh-B*phhdCh#HB*phhdChRrB*phhdChRrB*CJaJphhdChwLB*phhdChipB*phhdChPKB*phhdChPK5B*ph&aVu֒ 1gdRr  v1$7$8$H$]vgdm & F  1$7$8$H$gdRr  1$7$8$H$gdRr & F  1$7$8$H$gdj>l|6UVWtuvՒ֒גߒ36^rv{|}~ø΢Κ􄭄yhdCh"B*phhdChB*phhdCh^rB*phh-EB*phh-Eh@B*phhdChU1B*phhdChmB*phhdChrtB*phhdCh@B*phh B*phh%TvB*phhdCh-B*phhdChRrB*ph/ɓړ  169DGHJKQ[uԔ,./ӽލލނwwlaVVhdCh2QB*phhdCh3A=B*phhdChM:B*phhdChOB*phhdChH=B*phhdChRrB*phhdChcB*phhdChRrB*CJaJphhdChB*phhdChX_B*phh-EhzB*phhdChzB*phhdCh"B*phhdChcB*phhdChB*ph!/7:[cdȕɕ 367BV^hؖߖ޻޻޻ޮޛސސޅޮxnchdChAB*phh-E5B*phh-EhB<5B*phhdChYB*phhdCh bB*phhdChqB*phh-EB*phh-EhRr5B*phhdChB*phhdChfcB*NHphhdChfcB*phhdChRrB*phhdChsI$B*phhdChOB*ph"XuPQBC#p & F  1$7$8$H$gd^r & F  1$7$8$H$gd-E  h1$7$8$H$^hgd-E & F  1$7$8$H$gd-E & F  1$7$8$H$gdRr  1$7$8$H$gdRrIL×ėOPQ\]bcu{ؘ*6<?BCTUĺIJ霑yylh-Eh-E5B*phhdChNB*phhdChbB*NHphhdChbB*phhdChkB*phhdChB*phh-EB*phh=5B*phh-EhRr5B*phhdChRrB*NHphhdChyB*phhdChRrB*phhdCh+sB*ph& "#*AopҚw~͛Λ()U齲ȜȜ~~~sfhdChi B*NHphhdCh^/B*phhdChPB*phh%TvB*phhdChXB*phhdChlB*phhdCh&^B*phhdChf"B*phhdChVOB*phhdChUB*phhdCh"B*phhdChi B*phhdChRrB*phhdCh]B*ph&RΛWqjk̠AyX & F  1$7$8$H$gd^rgdbM  1$7$8$H$gdkgdgd} & F  1$7$8$H$gd^/ & F  1$7$8$H$gd^rUVW\]^_ijqΜtg\NChdCh{B*phhdChO>57B*phhdChB*phhdCh`B*NHphhdChNB*phhdCh`B*phhdCh/B*phhdChB*phhdCh'iB*phhdChum8B*phhdChkB*phhdCh B*phhdChlgB*CJphhdCh}B*CJphhdChDV57B*phhdChDVB*phTUV[gmst23[^hijkƻƮƻƔ|qfqYNhdChB*phhdChbM7B*phhdChWB*phhdCh>LfB*phhdCh`B*NHphhdCh`B*phhdChH6B*phhdCh{B*NHphhdChbMB*NHphhdChHB*phhdChbMB*phhdChiB*phhdChi7B*phhdCh{B*phhdCh!B*ph̠РѠ67_efyŢϢ ޻ް޻ޥޚ|qfq^Sq^hdChkB*phh%TvB*phhdCh6:B*phhdChXB*phhdChrB*CJaJphhdCh4B*CJaJphhdCh&^B*phhdCh \B*phhdCh/B*phhdCh^rB*phhdCh.B*phhdCheHB*o(phhdCheHB*phhdChbMB*phhdChdcB*ph '7>wxp x7$8$H$gd"gdq31 & F gd~1 & F gd^r  1$7$8$H$gdkgdy  1$7$8$H$gd&^ &'567<=>?KfuvwxˣAteVehdCh&^B*CJaJphhdCh4B*CJaJphhdChrB*CJaJphhdCh-EB*CJ aJ phh-EB*CJ aJ phhkB*CJ aJ phhdChPB*phhdCh@vB*phhdCh|!@B*phhdChkB*phhdCh~B*phhdChXB*phh%TvB*phhdCh4B*phABRX]mnoprstuv128u|ƻvk```vSvkkvvhdChtB*NHphhdCh"B*phhdCh~B*phhdChtB*phhdChB*phhdCh-kB*phhdChkB*phhdCh] h] B*phhdChy-B*phhdChB*phhdChHB*phh-EhbfB*phhdChbfB*phhdChPB*phhdChPB*NHph puBdef%&VW & FgdmgdPgdzJgdsAgdzJgdP  1$7$8$H$gdk & FgdX_  1$7$8$H$gdtgd~ĥ@BDFUj-/>?FSmnƹtlhpB*phjhn7Uhn7jhn7UhdChbMB*phhdCh+$B*phhdChHB*phhdChHB*o(phhdChB*NHphhdChB*phhdChWB*NHphhdChB*phhdChWB*phhdChtB*ph*&'PQRUVcdeflmߨ$&Ĺȱݦ}r}gZgODhdCh"B*phhdCh-B*phhdChzJB*NHphhdChzJB*phhdCh{CB*phhdChPB*phhdCh EB*CJ aJ phhdChbMB*CJ aJ phhdChHB*phhpB*phj]hn7Uhn7jhn7UhdChcB*NHphhdChcB*phhdChbMB*phhdChHB*o(ph&'<CKdwƪǪȪ˪̪ NOĵ|qi\QFhdChFB*phhdChvB*phhdChPB*NHphhpB*phjhn7Uhn7jhn7UhdCh=B*phh=B*phhdChPB*phhdCh5B*CJaJphhdChzJB*CJaJphhdCh"B*CJ aJ phhdCh0iB*phhdCh-B*phhdChzJB*phhdCh4B*phOo«Gv{|ʬ׬RTVWXjȰvhdCh5B*CJaJphhdCh-EB*phhPB*phh=B*phh B*phh%TvB*phhdChPB*phhdChvB*NHphhdCh9B*phhdChB*phhdChiB*phhdCh(B*phhdChvB*ph,WXjqraz]zgd_g]gd_ggd_g6gd_g  1$7$8$H$gdPgdC(8gdPgd5gdsAĭŭέ37Ynopq̮ͮ ,-;ʯlm{pehdCh^rB*phhdChrB*phhdChsAB*NHphhdChsAB*phhdCht+B*phhdCh]B*phhdCh7 B*phhdChu<B*NHphhdChu<B*phhSB*phh=B*phhdChC(8B*NHphhdChPB*phhdChC(8B*ph$Űư_`ax}~skskZ h_g5>*B*\mH phsH h@lB*phhdCh@lB*phh@lB*mH phsH !hdCh_gB*NHmH phsH hpkh_gB*phhdCh_gB*mH phsH hdCh_gB*phh_gB*phhdCh?OB*phhdCh^rB*phhdCh {B*phhdChsAB*phhdChdyB*ph³ó !,12ݵ޵ıyf_OO__h B*CJaJmH phsH  h h_g%h h=B*CJaJmH phsH h=B*CJaJmH phsH hZB*CJaJmH phsH .h h_g5>*B*CJ\aJmH phsH %h h_gB*CJaJmH phsH  hdCh_g#h h_g5B*\mH phsH h 5B*\mH phsH &hdCh@l5>*B*\mH phsH ³ór8jjjjjj & F W$If]^`WgdBNK`$If]^``gd-EUkdW$$Ifl40 $ [ t644 layt-E z$If]zgd-E ޵Hcc & F W$If]^`WgdBNK & F W$If]^`WgdBNK z$If]zgd-ETkd$$Ifl0 $ [ t644 layt-E*e/P & F W$If]^`WgdBNK z$If]zgd-ETkd$$Ifl0 $ [ t644 layt-E ۸4#$t $If]gd-E & F W$If]^`WgdBNK z$If]zgd-ETkdz$$Ifl0 $ [ t644 layt-E $%'@ABMO[ܱܪܐ}r}gVI*B*CJ\aJmH phsH %h h_gB*CJaJmH phsH h B*CJaJmH phsH $%&@ANvhR$  $1$7$8$H$Ifa$gdoY $1$7$8$H$a$gdf  1$7$8$H$gdf6gd6  1$7$8$H$gdP r]`rgd gd_gTkd$$Ifl0 $ [ t644 layt-E [\]^uvLMfg9:yryryryryayr!hdChuB*CJNHaJph hdChuhdChuB*CJaJph h+Yhh.g hvh.g5B*CJaJphh+Yhh.g5B*ph hdCh.ghuB*CJaJphhdCh.gB*CJaJphh.gB*CJaJph h+Yhhf hvhoY5B*CJaJphh+Yhh 5B*ph&N]^vn_HH & F  $1$7$8$H$Ifgd/2$1$7$8$H$Ifgd9{kd:$$Ifl0j 5&  t0&644 layt_g$  $1$7$8$H$Ifa$gd һu^ & F  $1$7$8$H$Ifgd/2$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g &<Xzּu^^^^^^^^ & F  $1$7$8$H$Ifgd/2$1$7$8$H$Ifgd9{kd`$$Ifl0j 5&  t0&644 layt_g Tiyuu^^^^^^^ & F  $1$7$8$H$Ifgd/2$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g Ͻ 9Lu^^^^^^ & F  $1$7$8$H$Ifgd/2$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_gLM^ir}־u^^^^^^^^ & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g -Ffgxm^$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g & F  $1$7$8$H$Ifgd9IWuu^^^^^^ & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9{kd?$$Ifl0j 5&  t0&644 layt_g {o{ $$Ifa$gd  $Ifgd9m{kd$$Ifl0j 5&  t0&644 layt_g9qZZC & F  $1$7$8$H$Ifgd9 & F  $1$7$8$H$Ifgdu  $1$7$8$H$Ifgd9{kds$$Ifl0j 5&  t0&644 layt_g9:LMfqbKKKKK & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9  $1$7$8$H$Ifgd9{kd>$$Ifl0j 5&  t0&644 layt_g7H]m|u^^^^^^^^ & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g u^^^^ & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g1PqbKKK & F  $1$7$8$H$Ifgd9$1$7$8$H$Ifgd9  $1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_gqZ & F  $1$7$8$H$IfgdbV  $1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g+,23:JZ`r~ 8901~ݻݦݓݦݓݦݻݻxhdCh7-B*phhuB*CJaJnHphtH%hdChuB*CJaJnHphtH(hdChuB*CJaJnHo(phtH hdChu5B*CJaJph!hdChuB*CJNHaJphhdChuB*CJaJph hdChuhuB*CJaJph+qZ & F  $1$7$8$H$IfgdbV  $1$7$8$H$Ifgd9{kd9$$Ifl0j 5&  t0&644 layt_g23Z qqZZZC & F  $1$7$8$H$Ifgd  & F  $1$7$8$H$IfgdbV  $1$7$8$H$Ifgd9{kd$$Ifl0j 5&  t0&644 layt_g c4vFo0 & F  $1$7$8$H$Ifgd9 01BqZCC & F  $1$7$8$H$Ifgd7- & F  $1$7$8$H$Ifgd9  $1$7$8$H$Ifgd9{kd_$$Ifl0j 5&  t0&644 layt_gdeoGupuu_WWWW & Fgdm hh^h`gd@6gd6  1$7$8$H$gd@{kd$$Ifl0j 5&  t0&644 layt_g .Nabcdeo]^rFRZ[c˵˨ubMuu(h+Yhh]5B*CJaJmH phsH %h+Yhh]B*CJaJmH phsH hdCh@B*mH phsH %h+Yhh@B*CJaJmH phsH  hdCh@>*B*mH phsH hdCh#Z[5B*phhdCh B*phhdChU1B*phhdCh@B*phhdCh]i"B*phhdChdCB*phh_gB*phhdChfB*phG]^r"EFRd )Z[c & Fgd^r & Fgd^r & Fgd^r hh^h`gd@ & Fgdmc/OPxLMNW $Ifgd+FgddC6gd'7gd0L  1$7$8$H$gdP & F gd^r & F gd^r hh^h`gd@ & F gd^rOP[x5@HJKʹʬ١|qiqia|VKVaVhdChUB B*phhdCh4 %B*phh=B*phhB4B*phhdChdCB*phhdCh'7B*phhdCh'7B*mH phsH hdChdB*phhdCh@B*phhdChi>*B*ph hdCh@>*B*mH phsH hdCh@B*mH phsH %h+Yhh@B*CJaJmH phsH %h+Yhhl>B*CJaJmH phsH KLMmn:;w} !"#?@LMef?EGHPVgr !"ݸݧݕ݆ݧݸݸݸݸݸ݆݆݆݆݆݆h\1hUB B*CJaJph#h\1hdCB*CJ\]aJph!h\1h4 %B*CJNHaJphh\1h%TvB*CJaJphh\1hdCB*CJaJph h\1h4 %h\1h4 %B*CJaJphhdChdCB*phh4 %B*ph4Wmn<iSJSS $IfgddC & F hh$If^hgd\1kd$$IflFrn%J b t0%    44 layt\1 $Ifgd+F"#.?Le\SS $Ifgd+Fkd0$$IflFrn%J b t0%    44 layt\1 & F hh$If^hgd\1 GH!".i\F & F hh$If^hgd\1 & F$Ifgd\1kd$$IflFrn%J b t0%    44 layt\1 $Ifgd+F#$&pq $Ifgd+F $IfgdUB  & F hh$If^hgd\1 ""#8A]fglz NO^_ijpqVWsth\1hdCB*CJaJph h\1h4 %h\1h9mB*CJaJph h\1h4 %B*CJ]aJphh\1hUB B*CJaJph h\1h4 %5B*CJaJph!h\1h4 %B*CJNHaJphh\1h4 %B*CJaJph6uriSi & F hh$If^hgd\1 $Ifgd+Fkd$$IflFrn%J b t0%    44 layt\1"5D[riV@@@i & F hh$If^hgd\1  $1$7$8$H$Ifgd\1 $Ifgd+Fkd1$$IflFrn%J b t0%    44 layt\1[nAB[\TUabҲëҲҲҚҲҲҋҲ|Ҳҋmh\1hY'rB*CJaJphh\1h!TB*CJaJphh\1hdCB*CJaJph h\1h4 %7B*CJaJph h\1h4 %!h\1h4 %B*CJNHaJphh\1hUB B*CJaJphh\1h4 %B*CJaJphh\1h=B*CJaJphh\1h-EB*CJaJph'\iSJS $Ifgdv & F hh$If^hgd\1kd$$IflFrn%J b t0%    44 layt\1 $Ifgd+F\b+{   & F hh$If^hgd\1 $Ifgd+F 0>riV@@@ & F hh$If^hgd\1  $1$7$8$H$Ifgd\1 $Ifgd+Fkd$$IflFrn%J b t0%    44 layt\1qr_`tuv78=?$%&UVcghwxyпппаСпСК|rnrnaYnUMjhJUhJhveh$5h h$B*\phh$jh$0JUh!#3h*RB*phh!#3h!#3B*phh2B*ph h\1h4 %h\1h="B*CJaJphh\1hdCB*CJaJph!h\1h4 %B*CJNHaJphh\1h4 %B*CJaJphh\1hY'rB*CJaJph!h\1hY'rB*CJNHaJph>Cv?Jkd2$$IflFrn%J b t0%    44 layt\1 $Ifgd+F & F hh$If^hgd\1 $IfgddC%Uwxz{}~ $$Ifa$$If$a$ !$&dPgd0Ly{|~  |h!#3h*RB*phjhn7CJUh*ha'CJhmHnHu*jhn7CJUh h$CJh h$CJ haCJh h$%hahaB*CJaJmHphsHh$CJaJh3]h$CJ\aJmH sH jhJUhJ  gd0Lskd$$Ifl0H$044 laz&P+p,p-p.p/R!4567:p/ =!"#t$% 5 0&P:p2=/ =!"#t$%  ;DdXN  S *A ?LOGO1bj:"&d]â$p%$F:D+n>:"&d]â$p%$PNG  IHDRlm8R PLTEfѿѤtRNS@*bKGDHgIFg6 cmPPJCmp0712Om9IDATxMn$;Sd@#)ԋH b Rv݈+EOtaeNM ό4#?Rf ˧fF㏻z[NBܭB~Zu^B9v'*vés_J,t8'QM 2M ?qxAޅ-> ;Xᝥ[aw 8Ww5ι<\)[ v [9ANd (Z`M{Y+*B_lM vZ}-%靺 pjRS *-F åKRNb*F0E[[;5^l\<$85xm\B!9\8+39 o9=q;/9P6e ,byˁIMClyRE2$ *zs3[yb`l]DZ_HCZNIL1wY\%˷f":jV~xN y= ӶQ9% J4x:?8\Z&nɒ j?F/T "6ugMNyڋC4d6 Ost5} *S2Dpx bniȇ2:+rqFGM;կUFkNXaԧ- SrJF<\X2d{X iLJ1_m;ül}ZZNJ-twl: o-ýC,Fs7J[L[*d&AT8ާ-:3taadWġENza1b\(Cx]e6˂ CO`Yt=Iǹ(;-0X#3rʶ4Mq8&}nf+ч "0LQ3)t8n)rhxb#ؑiq$Jb)eqqJsg}2pBrŎ _8Ub(צU0#jp} O;s'/)> PɌC$AC, U'3l k|jgT,8<P 7=X 09\ 4`o&zMN76G'\rpb#`38Zn hrahlëBsV+g:殺)vL\b[@q`dlfy_bcCnw{v ;Y 7ՒN6_B#etPv "ۑwwbsTrx.9ߝ98O 9c@'DimlWSu7b'QS 4pmqiJ՛'G6b |8dѤ)Wj g׻$(T2b;TR*<+arxx"CƝػwOT m^D^p8P8od-JrP<XFYa9 -,tr@؅,5ڨñ$€Ev;@&c9蒃yG;yIxsv8OIxuhq%qW b0"\# !d:9jjCf>S@dףHMߝqd9Tȡ!aJEQ㞮 papAAR'3Xf@4b3puqRB)5}8?΂.R\ 2V0Qný(R)@xs8ѬY'˔SöAec f=h'~LjusH9u8# a!h1~8H(^4!=E|G EI| "s{#Y\ zfr&+"TTYdyyZlB\&Xa C3mHUr9ȝ^P`8T~2֒ԅS(^^lb`:~5F/GD8_Ds(2a{KS'd嬃N q3]Gvϣ2./8[́ V+9@^Nީ+23Ár*2.7T85iLG |yQD- 8f k=JG'Cf٠&A᩷]Pr ϲ'@Ȣsp}|Ƨ0gu FLXL׾k7'OQ#] t3pCmK76hsh8f_?< /Cbs?xv_ #~M+ *$pDΔ c8LzzMy~jԹpp֝9JT$4#vNHqinJ+=" Ơf`^=8AS7| !UACA%!$6}G_S݅%A8KgC|{ǡc`{PQ"0 :M㆔pGǮAـaq5=IcdDIr@(#D .t7|Q ~n[8 q"ʙC5,8Ri/ SuUAߡ(}f?%I8+Apj!aVzP '1W0q7*E窓oZP#sB,=h?߾AucPjs8yf 9.8|CI8!:JˡN*f#0WgUaҹZ&@r8  ,&?&W X9@zMs%,HCrW/+nۏp␠}} qja8|[AA02U@n8p8ܬp\!a~Y39<xy1ȠI; ܤ- '\| ջ&8h[}nF?JM@ aAQrg9kUC*g@p>u%׳ʈ!Xδ2võ;ҹ9w}j~P#ǁ ~@79+_e 8\Q,ݛ8\ˮˮ5c99 pq#{LrݏfzPyإL+8oeX8\fq 9\s sK/5ǒ*v=r` I 88 -r8v. p3\73Sw\ P*gg p c3Q:HE7,y_{3:Dj`4!VadNjZey,v>Der JwW߂3zٙ]AMŰ'v5̙W<=, jD^!8$dK8(XMg +S rr Q9 8(zC*U>s7> s@M1÷+ȏ{S@DCqg!9e=\s-ߚlV9yG 1 3z9D~*j^9n? 95~_k/p7?pp^Ab"?X9ځôsTw0o xBqvXǗp68L$DqqXh {>~ʖ@X?w8ݞ[nV 0[&}9Lqx` ջpчgWsAqb_w0Wp#M00CAþrW9 O `Dkڝ}71^I8H(g8\`z8TpGQ ^<$ 3kAedǸޑ怞>hj`Vp ;ƮqT2:=dk!J9<_sq꟔~o }.NbÇۃLJ㤁rB)9cV_AasЛY2x208zDWd8<ix?T9/f'GC1>݃WMSCX:EǸs*9kvaϬW&9LGy9. 19C~n9(8H$  ]r;9ds2ɽ8J{ʷkRųLn8L t_8?(m9hA`,^ MC0RDDt$oXAP.྾;0* މ9?{8??/PjCmv#w{8BC9rvqycA49fA@  "Bss57F=>,_B-';d-^l,N~Q=&ZT謀ÏOj ?3`۷C R[L0?˂xD&ch,]1ܝEHoPCj8+GTy.#=<bca\*b?~C,Xrb9.(3a7$|ػ499xKyF"[TptpXn A0/0oDPV76pK R*PU/[x"W,qxH|ᥪ/Ըe%F_fMɑzM))ӆ7ܙٕۚ;:Urrg^sU+wtYP|D8~d, ̞3HuUI<i OWf8Jwqh<&o?Ej!K U% |0w`rh<&5r9_}9jaWË?gi.i[f9%@-9&9p?u./_.L9=A%Ccn({8;-Dc^PqVМ/}9^x>9;-+A~V5]9!^s0ݫ\tE?@ šI FqnKҔJrzxFa.}"qH",a?U$AYZ 8o=_\b7;iVٹݸD&A& -5[@`c98G<zUoT_CQ?-)=Bd?_̹Du' z9o~BâЫJ!49^! G/vgcntq==pTZ<6ׯHBCaK{ 8^A}`Cߐ?b8(ϜHV~=} {`;*-ݰ0@cCnnRĵ ft&&sH|+r5^,!\ȕ 4{H͆92 2So!Š-! ߺr*%pE1Ȫy«}9d69Xuލ)9_?Af=*J %Ϙ  |ApXY!:C;/~W KpP0_&d85U\?h DꦊD؍^qi/;r?5*djqw0>b[ɷ8=yɈ;;9`b-2wrf beAZwrŸυeCq@w~=AS֠lA)Om0NW9mu8HqQY 78*{He- -NuCؚ|ڃ?saӆ~!ѧPFQD6VW%]y!> _A+9:sy/ q/0"tKgp r#q~ 0uA76qW.𴊃DŽU_#AXa9ELq9C80|Mk8h_8{q6$Bp09=9)&xdbiwqmYD8|tq0k8uFϡXoAP09)'pV9L!>i=BtTŭ~z=AA~QLC =?I9:[G2Gh V9 VsRlo29%!=ơ0.~3D6q'#'Qpޕkk9-PaZA9Luj3טMp),8fU.C BtrȖ+&C<ϵ/C=(l0a Kuq/9gE`4qx8 5.`!pTpȋ2n j졛pPd-9WONuCEBn0,8^^&PrC!@P1s(kqr8o0)ݥ2f3H8N69kChrx`pI~<P,"IWv%|θ\ lSir0! kq@bsQna KA8{wFe,9(\ױ4xo8 m U8<4!JqPz5gBaNy@842%!t90/eX`l3$A,ji-\AuN9 sxe9'HECb{k,E(_-> INؤ)K}hJSǩspON th} ` S'r"}%6]Y`sҥ%8bM]7p=/øF8kgT= p,|8h.2lpFx8Pob&5a8 BXpx`o NK800 pًÀstp8dp1;(9'Aºq &V]<kR"=kA&6pЋ92q.PBZ"8u:pX`0ќCP/7*>8] 1kEɷAsϠKJN)Hdpi]{!ok~|,C*! ]Bcz)\/٫G,QV졋 Icq9Dsr0W qx{p0XU }7jlP]NVl0 䡾'S=sW8 j=(p SaU4Xd9\1.nc&8ap8S$q~ ,1w.0uv\90u 8%a5_RP,`U8yr*!QQF\Aſ ]1G⑛(j-e0Y!- f79 Dm5o,qNCS'#ꑖC,etA+p{8Mpٜ,;d  >!_rVRοk̅p8-pX^ ⼚i;s1: rHs7Eq )=.5p7eNH=sX c;<δlXH9O|n AOhJo68̡ SpHA58 K9X%:L6gl;%R/'N7݋eJy77w8fzm#Ømr-I1Rdt7EӢgV((h0mb!N{GÉ {858C6`F$RrEe2{`{ВK CQ- aP|9&rɁ9HҍPrk z搼ghùZnğ8HPYCpțr~׹=ȼ.(b%TLe-0pRd'cGz{0e$&԰ !g048 [fl[d8e䗶p(EP)Xp`VqHNJ8v9RxvEyNXr1eH9\d3 ࠋ0Pu)zpA$MtTYcCjn6Lr w\2&uǂ JWZ#lLCy0R2<`2o+)d %!9 Hl(9NB3ޘz(S}Ptʝ9twi@.tN$A9 5*Sɝ L ǁp"|HB3T0$:G&ȨH/rqD\A:5֩7XJ~u$G;+Af\*'5@t}8UA&M*v|MbGYAq I>Ax% էrK,e4^԰! 5ݕN UE͕(Wrx8ĿR'x%>K)G&و%*|XơL{~9RĎfsAq敻t DrI(%b9UPG=w08bYsR@m ,)n堰uY7Aa˛^X)ҀA#pHUr~7 8 H Ma'`I=p(2]srd9sH!yZ JK %P gAl !D❔('<1K$C˲8T8Dsb7/9HKbӵ~!sWWx' CGdʑBfQw(7DxgWfs&wW+yyyERF@]|8KQ"u%ŹcǷJGrNr9&8/h#khg ,90{:8ټCrߑ0k8V pgWpi֥F&e%ty᭚^ w$*8ۥPNc]wdDA=@924vA͙~?p(9vo4!ֱ_I^[DQq-{r`h{{l TK NW"U GNrn8;@奈 99EC,5dS{QB5O6rP5)yAv%Vr MGmqAqnosdsF^^YAYyUct|q!.)*n u}Nvv/C+ݭ'F%Ґ>Cfm KETqKzTn%phqX?ź`8 kSFKx9 BKк9X-z9޺RoA{SlnCN +phyDg!` {EsL*4و&Cg f; pwTtHquDhnOVpk0 9X6C{"LDs?M Bjr څ0VRS\Qߺ8tchr%r+s.Xn(3{⬻փ[4KQ9!:Źt/Fא4ivAd0mYC6 3\ԀTva8UeM7 Az$*vIN^t:Y3 phdu{RvۉuSv}#vYi;u56O-o6uR@u͓?/Ph#{!jϚU9w)AL|I'q [QbQjTB Hj8zk/Uzl'@$ V&q nsḱԣΡ_(5fUR;9Т(nppRHXfaNM`Z.Wα@ǔ+0 00:.pXrvl^T.Exat5i!+ʐqXf5vqyI9|jE6>Z5Va(9Me0r=ıɡnEcFu$s`]b!f=^It˵c"\=^0m8dQQǮ vN{qꨖN^0d^wA,rgk @8A||[V(z ood8iR^5/O!mSj\갰.s]yl{Rj?t~#IENDB`}DyK _Toc264194073}DyK _Toc264194074}DyK _Toc264194075}DyK _Toc264194076}DyK _Toc264194077}DyK _Toc264194078}DyK _Toc264194079}DyK _Toc264194080}DyK _Toc264194081}DyK _Toc264194082}DyK _Toc264194083}DyK _Toc264194084}DyK _Toc264194085}DyK _Toc264194086}DyK _Toc264194087}DyK _Toc264194088}DyK _Toc264194089}DyK _Toc264194090}DyK _Toc264194091}DyK _Toc264194092}DyK _Toc264194093}DyK _Toc264194094}DyK _Toc264194095}DyK _Toc264194096}DyK _Toc264194097}DyK _Toc264194098}DyK _Toc264194099}DyK _Toc264194100}DyK _Toc264194101}DyK _Toc264194102}DyK _Toc264194103}DyK _Toc264194104}DyK _Toc264194105}DyK _Ref241459143x\DdG<-opL    !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDILTOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F rK)Data SWordDocument<ObjectPool r r_1407070976FrrOle CompObjsObjInfo  !"%&'()*+,-/0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`bcdefghiklmnopqrstuvwxz{|}~ FMicrosoft Visio DrawingVisio 11.0 ShapesVisio.Drawing.119qOh+'0 X`lx  arglcajlVisioDocument N}VisioInformation"SummaryInformation( DocumentSummaryInformation8 GHVisio (TM) Drawing }dQ5|aR |@ ]|%|xH /I8+  !fffMMM333IyfUJ:DT5I[1hXT@. .Ub##/a0zGGz?K&[&/~&b%*~ !oL $c)PF?#~~,, & "& , 4&?Cp"/.?L74? T0A  }, ,,'p/%O6$X6 (}j?k)?"   34#o =S?#A:;A;dUdU@;dUdUdUAONOD`;dUdUdUdUdUdUdUUb SR~;4OL%=Qip;RRRggRph=Qji .@]E' @%p3~|bFp#*| | | ui?>>QU'./o__v/&DA灸/}jUQ\q>6qL=  /Av^p߹PEcO(?\.bߘd7 '9-(f=DB%c8?>27PO8{I7Er oOx`[h4FX48^L=s -)q~UFDfP h>(/T6D UA@ m?I?4E P?O@HZYZwإ 0`PBox},ragad,eWctnl,wi",Sp !B oWkss g )a !r,"e2 7!#cn G!A!e"!er$eȍH?/ܭ&?+0e^ % R$,^O1Y?i/?XE'0U2!0E7u P(:{W_qDrag toad ecanl\thdwwi pe.sJ&s)a?o&@n(pygHmb?贁No?k?4 HD" # B=h,>TP]]9 UA??Q6 u` MuBY]A\A]<<U$*4>LV`MJ5 L@񣔍֭5 `?CopyrigTt (c)* 206 1* M" c. os f("!r U!a( i n.* Alp (st"eH e v dh /`V" sW_Selh cTm!#4 6754!@h-/?9 l>#0>Uhh#3 !EJT n :bJ[26{E 22M!>?A% O9O9GAEkK 6M=I2O;rA ZR"SqP]ol? VlJ?@T"COSM_[W.0__OMQk6UX-iM3U%\oj"o4oo Tkgol(GA)e(KSt x( eANPBI@=kgCTQQNTvRTA C"(ST$@ qMJQ3UQNPU]H'+. !OyaGEFQ #YReJBĀS]taZBo#K@$oK/3aQb#P UFDfP h(TPYYBUAm@ ?I?| P? tO@HZZwÒȉHq??6U!B^:  01`box,rectanglI ,;bO siK  e^ q%* iu//X|'|'0U)2!0|7u P(:{W_qDrag thuesapWonodwipe. cuTm)zdbyg*aTXslci n!z:mb?贁No?k?4 HD # =ih0>ThE= UMA??Q6 mu` uB2 A @@A@V(.8BPZdMJ5 L@Rֱ5 `?CopyrigTt (c). 2`03. M& c$ os f,"!r Y!a, i n.. Alt $(sx"eL e$ v dl w/`V& s_Sbb .2 hm!#4578 hH-/6# '?9 2E& ?L7  l>aUhz!JT r :y1UbBRF  x2;BM! NOUA%aOzO!IAQE5KFMMIR2O;2rA ]RcSq4 ,bP7E?7VJP\11"SOSM[ ?UViM&CU_^D0oo&]Q%kFZg@gnoWoi5\oVj_o i(y1e=J0Hg1e*T72TAI _"(]ST+&@qMiAb?=d=XQ7?'2%q26!]ea ?MHu+ nZU"JLM%FܺQ4A#ZRuJB $M]za\@9@oK=3a,7QpPP t4P)&@NhH @ DZB^ AJ-43h7 t4P)&@NhH @ ZB_ A-%d37@ QrDR@DQCRH<(H<(EQ REQ R($QS\%K!7=BVh!lQ/?ԵQ PD|Q j"X2 mm[@$I?$I@w "*^p? N(^*U TCUW` ,m۶m[@$I$I@ LFDNTyB@ uh TPrUAJ^%@ANhH @A-?4I?FP ?]4jr rtR FN12'-?9-.(oru`l"v"F|"uu)eUK-$>n!!"#$%&*09=T24BCvEjU l!JG Hg1534u;4;!8;18!;81; 18;4 1;8;g18;k18g1;o18k1;s18o1;w18s1;{18w1;l!8{1;18l!;181;181;181;8>81;18;%4#1;#18+1;'18/1;+1831;/1871;318(>718)>;18;?18;C18o;%4Q>4;24|!;45;S18;W18>4>_18>m4>18V>54S>18UU:Po1o1{1{1|!l!l!11111111U*<N1E}%APEPE;1)% %@@6i @@@@K~?C- K?of#|/?/l#v"w"#/BNayef0cUorit]o /lukgof%dasuc s h'izli sk1VqZg5r=1(!EW8XE^}0'2Ufduf @xq"%k1v!!3EWcE6֕\n/Es/#/5/G/NGu////qE///?EP?b?t?? E?????Eq*Ob꟪Zh00P`I T }m.4 wt`arsDS:sSL5˦|O4O?c㡁!3EOOO_o)\q<_N_`_r___P__o%oϵ?ljVomJ7oѿo$R+@@EDTm@@sC 1vt?Qc}@@wyINbqeRr Ibzu .@Rdf߯}rb&A }rbʟVPz |'$hH˭2FrnrTa@?aJa;oMo_oqooj!(g}q ;/bZ @@bX,?@P(_ ?$%1+gy{u66ӏP*_?߹ҏ(tΝ&O6O \%$_6_b's_O_˯O__C_%E<36BTWIhpvfɷGGw"VOhK~El ϝNHZlk6F'K]|*t |b^t~E\}tzA]o$Gt̏ޏ 2DVhz?߰ "//*/@@K %"ȿڿ&= !:9&1##?#:ugutnIyx)RbbbzF2bIbyb4Wa#S0O?贁Nk4 KmZl~'O/K](R "_ A?V#߿U _K'_k\%__w"___-ORir# V@bcU!.1AV forbMKHu`emKnt& AYa|@yIiI WdMm;p`ovhB*qcKsIscG=OOO6Hoc^r՛tZ)/ Ayjt Hɏr5t@ |Et _q&l~yc?6HZ:LH}A /q(s[y{u{b/pi?@ d25Į&///H)utFOB QL59AEOWOiO 3?=>?P?ɯt:}OOdvOOF{_;o_Z_4!_E_i7ŀToo3^my9lJk7`0bhbe*rVFPI pp`(qt`a qa0g>PV-ޟZgo 1ގ͟fxIp/6/H/Z/l/+'as߯?#?9K_qQI2A_MQS,7, 1f@@Ը?@|P@@jWZU UPB^pς2AjVIB(4ߝ_X۹\.m_D1_RmIy!X?)YbPdzՃŅ#m0P贁Nk?Bs$%ߙ߫6OߊH1p41B1 ײv[UWh|UR v6zZ\2XEr `T3n1 R pr HdD 2DV3v'ew1$7iŵqTA///4h /`/ 0/UZl~//??5?G?Y?k?}??Ŀ?@??5G OO@:L@TKEQOwKmËOOOOEԄ>'׃<@ ?@U@)P?QyHؒVlL_ co0oBoTofoOydÆgp` odؓoiKoo*؜Q.@RvE!Yk}b_׿x1C,//?"?4?F?X?j?_?<#50@7؃??? O@-$IѶ9OO]OTvE_8:_L_pZxOOOG/OOW}_______Wi{1oqoߐo,ooe߉@A82rdifyCRo CpupyiiEAFivEUV0#W؎|A 0 _I[ځПyz$?-?uqӯ _?7A @@ ??Iq$I06oOϷOO*EN`M.@Rdv߈ߚ,ߚoUoo2_d__o"o@4oFoXojo|oŷ.bc 6"@ 17AdOoЃ!@@ @CZ/7Ϸ6$п7d!ό?p&8J\n؇Ҋ_N! h\wa$THXPLH ru]d1B 0i: 1 =? &>? X_5b4BbrO5"Ο(:JO  ?@7]qX'ͯ߯'c O^ ЈpJH*P@{ %Pyofh$i{|Wi{ύϟϱ /ASewߛ߭߿Uu[jX ӖuAJ?>Pbt-O?O#  AC4%:C+Ct'//YEτ. @@{0@@ƃ?@{4^(CU?PWARPƂ Xa,ƅ0"=)#J/\/n.%\0'\\ ? %‰ҏkPoBUnUg%noq^ox>aWwVV܆%Eqƅ~֎u`{6vi=BUi0z%VnyD2(sEComp aints F,aw%IVD唎xXWh'2UfE)$>aBEhxgwtaqtzɎxSTa8HBR(Zh<sEp6d?OA# OOۯ{ _.Vty.hyV_Us[JY}YJf\___D\Ts2 q밬?cdk?0YAyۖ_4/_oo)o;oMo9qoooSo ooBڂzKoϷ2CUpۏq EServFc +Rp53^_=_//O#G<L^p[h-WP5oG>oG@\h  dpDqrsK uLapeN/r P0BT'=ax6qT~% )a!lVBhz<*i>"GYl?!eK/i!ae/Eί௪/(,o?^LaB@@{ǂ0v;0]M0MV?h?z?????ޟMN'_O~Oe8<);XX|nA5To8>Boo&<3Poyzuppwr 2@fopmpncp/)Cmprmpl //(:{ns%ΉV!?;uW4{?T QcW/*w/\//////%։A+qA;8r@2PG?Y?k?}??l??? O=1OCOUOgOOOOm_O,/_A^d_ψ___R_ _ oo:oo^oo(o oomJW*dPrxqs }ޟ K]CUgyGi *\nF,Pbt0/+i'K/oɯ:d@@{0#0~?@JfY%-?Qc&?=Ͽ);u/_qσAHO"_O]F%A^O8XO\n߀ Opk&vX2pn%]_._)oL'o RgptUprupe)dcr@dUpc=H~Q 2D%#|B( .h?Rdvk}K6$M/П)/;/M/_/q//*_]/////??0?9?K?]?????????O#O5OO_kO}OO0ϳOOOO __1_C_U_g_y__ro__ao_j oo-oQo߀uoߙoooWMa?kb /5c`s=om`r5sbv`y5Qc8J\n V 6 Xuď֏" 0B7Ix Ԧ*HJ3R1: @@Kh?@7AМM?@?"G%PRT-u `u x bu`u$]@"(v(!{"v"!#""$-u` M#u%0e.jjQ 2-2(726)6L27=ܵ@Ӏ?@Ygbn @@%?~?$67727?567=L7 O0Z(#0ZBuH>PXj|ä0p!,,(ғѲ1w 0޿M,G%")R# =(%$P#D)Tu[jP ӖuA_4_)f#1B 05 9Q:" 1 =? &>c? G%" 24!B2uoogr735!j<k}"y0}E_#!ZyH$R+@@6i+c4u0 u?I// bq#3b/ARXyOObz!׿o_o_TbrǑ x'ZwB%oPN͢t͟[}Ɂ^ N.2QXupQrT| ¢ȣ q |" /z&p!se u@@6Qsõv !3 @jxLL/QLSx\2qƆ?ϗL?\.?rpM1pAypR~OErOOOO\ЏwOsן°'KŵbtHԱ[ѱSxJXjExamp|esqpofqpdfindqpDt Surc eSSe߉ŔXO $'2Ufž D$gQx8ALMV]o t =8M=O a Mijء '=^uXK&!3" :&)*̾,> +ߢkt// !I2 qrs 4}q=#? "FTL%@@~t{@@1ʤ2XtD XP$b ~шEG`b`u͠`bu a50D+a"HHaAB ACBBT@!rq$VVҝ8OkXm i@p° i@@=:?$VVWUWRUW_UVVW]eWoPnπXo $षϗoR'A#O0P贁Nk?jrUsd$D9K]oءѭQbI1O *Oti5wuN81:!??????O#O5OGOYG.-$$@@ݣS8@@~̵P-DT! qOOOOOO_"_4_̀:!$ʖo_tV?oMɥ(#އU@ʖ&ɗT'9ʖn:ٗx:oLoɯpo@oooo oo*<N[r(4+=OasYGhu݀wSs /ASewKX4Ι>㟁]T֏,x}TիU> =T>Mﮯ={,>Pbtοi:L^pς&ϳ 1ώUn߀ߒߤ"LWQΙ&W]@&7'T?!>&V7"='`?"4?Xj?' %7D[m _%"4OXj|>P6i[//)/;/M/_/q///qQΙ&v/i ͩH @Rv`ɏۏ#5GYk ( @Rdv&k/Q,@@t:NLh -^h ޯ&8J\n%Yж)@@#2_ zvj ,4k}~ ~ K2DVhzߌ߰9 O)-l/c[)Zl~/@DӍ?@x Lh3FXj|A!*yF'T$-jb@@SF/,)?{uFGGtONF&WMG0__(:_^p//$/6/H/Z//~/i>oכ<1a,S/UanyiSh%?ehB2uoo 5{9i @@\}@@0>]?@C0mh? ?@]?PP4RaPObO<1q[2x'oqL1e 5&o8oJo\ghQ0kgC1K9hQ`hR`?b[5oUo@ao#a?[oz +{U Ӟ(?/{ae|;_e[5| 埥 88=3O5Wit/0in ea]c/0 dMtM sourOe ?sUaA=7e6O5L8XЇ'2rRO5!/tI; FtN ,[3`hQI42(?:?L?5p?z$R+ QE@ߤK~W5 /R=O T֪mQEy_ߝUª_Ub8gdQ?Iyx:Bbbbz15bI?bybC_BSOTShlauoՏ /ASe`ٯX‡ Bǟ\mS y5yYȭ2WqŶarUa)@q34. E_Zb]`iT_RDWSasIaGdICe@eiak!ztȩPEʱUտP Ȁsx"jv̕ѭ!3"\w>0VBbk,/>/̈BIq0EW iVύzʡ(ǭɡ9 %@@8x@@đ?@֏?(D0E?P(-DT!1`Y1uFﮏ=د8,ÝU'9q ˝)F_G!oEl2E\onosoooȯ_Wo{o"U0FKeUbMkk ??!A8 ( Qa\s//EQ Ϛ#??? #FG?@d T@@$a ?@%䧃e035\AEQvFŘ{;&Z4ES w&TדUOOZ37Eه@..@'#=$+:0/B(C_?.__)'>:@;8]Befpf1TSPV9f1~8FrP e2fko}om qiQ`5 tTp0Nѐ'96S~81V}ρ$?6?ɏۏn__?"<s/./v~MDދ{VzE?Ȅh҃?nq O6OHOŘ8|Jד6uOObOOOR_d____+//=iC+odvYceі V?Pa?gf &@ t@?^oookoc(:L^p qeU. UUt4 J^%@NhH @<QeY'}C T7A t4񝩏P)&@NhH @ $TYA-\B7 ;n@QYKR@tQYMRH<(H<(nE@UZ RE<@UZ RU ` ,?U#@+@ LF:DTyB uh TBrUIP)&@INhH @A6?4IF P ]4r u2?or[u`F"&","uu6)e H0t!t! u=! !x!'$+$u+$!+!(!+!(!+!(!+!(+$!+!(!+%$!+!(Tt%lPOOOOw"5}!3!E E!!|5/E>'@@@@PW@@U U?QAR^obidz @g"#0OWNk2W7%X8-Y cz hD!!%`sD !5x_z7 W!\QpuV~Uw[5p~|5pqM___'Z!wVPe x|fʼn2Ċ[5g$V7BImprovk mk nKt i$P[5 fXW[4'2#U!&3ag$rE ܯE_AST(8<Gm?_%5H|3Zj&yg9_ASe_?@@8?PwqH?@Jq?GOż?oQ,/?R/#&#B#|2Y_t!OLuei=$ 7oIo[dajPՙo[2X8\ 2Qì?߻+?4o=O|dy2 zz2-zX/{~HƏ4'Ŵ|QS}~=a ~ n siŠaeuV C3x?Ã!Ы!xc`Hbr qj/Aqa(ߖ!3&zC2܎>#`nqkǨ!K!Hxҿ:,@$PĩvOsasϗϩH6_ϓԃIO/ڼ:L׻ohzߌ -?Qcu_2_O_ l.osvo_o_"oodiWfycR o COuGTfxU"4&X_'9pZ/l/ /O(?>/P/Џ⏆//!!,$///_=!!tZYn_xR?.2"@@+FXϠ???5?_O϶OOOOU_"_4_F_X_j_|___ 2D_χoTo0oooo[߿@ϵPh*hz{AcIoAsx7ecu!1//);/??,?PlP?b< |4|5w?@ߎ595^Nr̿޿4A_@O]dOvO[J1CUgyϋ */A/ee/2߉,//ߑߣ/S/?2//[?/Zz^HDptprmpnp EpfTpjvyrepspUop lpn2de}}BTOON&O*z__ݟ.@RdvD؜@ @Rϯ.@)9vw+=Ojso//'/???o/YbtߝOO߼ۡ]3?3EWi{?F&`V@@qL@LP-DT! @Z uV`u bu a_PdW^"hh^1abasbb0t\ursU svYb#hC)hg1SvBwrwv@.}w8DA2#S0CzI&aJlIy>Eo7?/?U*C/ d]/2dSoi:˟T}K___oo)o;oMo_oqog\d@@MB8oooo&8J\nKsduƣu4MA.5/uϒǓ2n8Ҧʏ܏$6HZl~Ɵ؟8J/ASgyӯ tJd2!@@MA@@Z?@M?@PB>dPgyӿ!.{r r* ="@@u } JK]^ߒ=dDGYk}ߏߡ߳ߍ1SMFv zdwa$THQPLH ru,?J>1B 0ғv: 1 =? &>c? 2€4,BOO,Gr5,r _R&8J\n[]@@57kR0R?ݿ!3EWi{AÖE JbUfKfUfxbcmK@t@@@3R1@@~ %puKf gJgonKf+wmxg5//,/>/P/b/t////////??(?:?L?^?p0|SpYTu[jQ ӖuAŏ????OMO%O7OmOBkA[OOOOOO__*_<_렽bP`&SWC(`k^}^X'q______oo )o [/ oK&[@@@{`&TaeB|t}Ϗǐk} 1CUgyӏPp0pYU1aUgyӟDV /vt@Un<d'KRYB?̾QJZvPDQZvPWX[9U1( UO"D&aUAUNj )h"T} U+U |ɉB&Q- -H*=(XiwEQ//,/feArial UncodeMiS6?/?`4 R$fSymbol$67fWingds*7 fEArial"z@D/ R$fSwimunS$fPMingELUw.6UfMS PGothich@ $fDotum"|i0@ S$fESylaen  $fEstrangeloU dsaz@D  R$fEVrind1a8MR$fEShrut1i$&<fEM_angl$$%>fETungaH"@&>fGSendya{ (  R$fERavi"&5<fGDhenu|"{a (  R$fELath#&<fEGautmi &<fECordia Neqw8 R$fGMS Farsi{{ ( _ R$fGulim"|i0@ S$fETimes NwRoanz@D$DKVlEBJVl.BTJV)m%BIVNm5BdIVm2BHVm3BtHVmGBGV/n:BGVin7B GVnHBFVn-BFVo'BEVBlAVp:B@VqGBGuideTheDocPage-1"Gestur Fom aBlock }NrmaViso 10BasicVi}so 0$Co}nect_r ArwVerbin dCo}nectrViso 90BoxvisVerionBox.30Box.18Box.35Box.36Box.37Box.4Box.45Fluid powerPage-2Box.13Rectan7gl%%3 T/sE3$T?sG3@H<C"C*D"C*D@C@C"C@$$==_888% % V0<" *" *a<a<" % % $$AA( F4(EMF+ @$v*DU@HpgCC$$==% % V0*_*! #9! #9_*_% % $$AAFEMF+@@4 ף>@H<v*D"CdD"CdDU@v*DU@v*D"C@$$==_888% % V0*! #9! #9_*_*! % % $$AA( FEMF+*@$BBqDGB@0$=ARIAL6@|pmonitor>h>?h>&?h>w7?h>^??h>H?h>7Z?h>??   RpArialV x5uV |V OwZ T4``w |Z h]|OwPw@h3"|334 @lw |(|"|||H& w|(|"||| 3Nw>Pwdv% TxmivAAmtL\monitor % FEMF++@ *@$BBDByB6@|pmeasure>h>$?h>?h>.?h>@>?h>@O?h> [?h>??   % Tx0[AA0L\measure % FEMF++@ *@$BBDzB6@|panalyze>h>@ ?h>@)?h>-?h>5?h>E?h>S?h>??   % Tx3IYVAA3TL\analyze% FtEMF++@ *@$BBD8A6@@4C>h>??   % TT+1"AA+ LPC% FEMF++@ *@$BBD8A6@ orrection>h>]?h>n?h>$?h>@R4?h>$D?h>M?h>U?h>f?h>??   % T3a"AA3 L`orrection% FEMF++@ @@4 ף>@<0D^C?DMC92D3O CړD&C@$$==_888% % U,_&& &% ''3% % $$AA( F\PEMF+@<0DIC[ D. Ba D)CDIC@( $$=='%  % V,zy'/((S'/%  % $$AAFEMF+@@4 ף>@<0̙DBDЫBh. D¾B[ DB@$$==_888% % U,iQl&(x'_ ((% % $$AA( F\PEMF+@<0DiBDNBdDh}BDiB@$$==%  % V,`OlW&&&d&%  % $$AAFEMF+@@4 ף>@, zDvBzD2B@$$==_888% % W$D+HF_$L_$% % $$AA( F\PEMF+@<0XD#q6BzD-H BbfD#q6BXD#q6B@$$==%  % V,B"J.$$_$*$$$%  % $$AAFEMF+@@4 ף>@<0 DNBsUDByDIB qCĈJB@$$==_888% % U,1-V"V!F {+% % $$AA( F\PEMF+@<0gCj{QBHCU #BVCNJBgCj{QB@$$==%  % V,(5YFj+YF%  % $$AAFEMF+*@$BB8C@6@ Progress to>$>>$>>$>?$>"?$>.-?$>@=?$>L?$>\?$>d?$>n?$>??   % T AA LdProgress to% FEMF++@ *@$BB8C@6@ Phase IIIL>> ?>?>*?>@:?>tJ?>[R?>BZ?>)b?>??   % T $AA" L`Phase III% FEMF++@ *@$BB^9DB6@|pmeasure>h>$?h>?h>.?h>@>?h>@O?h> [?h>??   % Tx=AAL\measure % FEMF++@ *@$BB^9D:h>@ ?h>@)?h>-?h>5?h>E?h>S?h>??   % TxF:SAAQL\analyze% FEMF++@ @@4 ף>@<0UPDhC,SDrWCVD Y CWD0C@$$==_888% % U,@b!4456% % $$AA( F\PEMF+@<0Q WD>BXXD B`XDr3CQ WD>B@$$==%  % V,\vd526i46$5%  % $$AAFEMF+@@4 ף>@<0uSDBrHVDBXD9ָBXXDB@$$==_888% % U,KNei450'626q% % $$AA( F\PEMF+@<0^SDBUPDYbB !SDB^SDB@$$==%  % V,BLNT4!4454%  % $$AAFEMF+@@4 ף>@<0ICDXbB=DlǢB"}8DI]B/6D>B@$$==_888% % U,.S0q/ .K-% % $$AA( F\PEMF+@<0\5DâEB6DGB7D>B\5DâEB@$$==%  % V,%2t--^-t-%  % $$AAFEMF+*@$BBGDnBB6@|pmonitor>h>?h>&?h>w7?h>^??h>H?h>7Z?h>??   % TxMjuwAAMuL\monitor % FEMF++@ *@$BB{t%D׫@6@ Progress to>$>>$>>$>?$>"?$>.-?$>@=?$>L?$>\?$>d?$>n?$>??   % T AA LdProgress to% FEMF++@ *@$BB{t%D׫@6@ Phase IIIL>> ?>?>*?>@:?>tJ?>[R?>BZ?>)b?>??   % T$AA" L`Phase III% FEMF++@ @@4 ף>@<0XD8 C2,DBD@Bzt D5B@$$==_888% % U,O+"L m " % % $$AA( F\PEMF+@<0DC{t DCD֥CDC@$$==%  % V,*!" +"!%  % $$AAFEMF+@@4 ף>@<0F}@D CP9D(HB 7:DYBۘBDB@$$==_888% % U,N  0U.[.0% % $$AA( F\PEMF+@<0?DM CܘBDC}@D}C?DM C@$$==%  % V, /0 40x/%  % $$AAF4(EMF+ @$?C@aCC( $$=='% % V0\ < <\\% % $$AAFEMF+@@4 ף>@H<?!CcC!CcCC@?C@?!C@$$==_888% % V0 < <\\ % % $$AA( FEMF+*@$BB"Bt@6@\PNo C>h>(>h>>h>>h>??   % TdG_AAGLTNo C% FEMF++@ *@$BB"Bt@6@ orrection?h>E%?h>W0?h>@i;?h>;K?h> [?h>d?h>ll?h>}?h>??   % T`AA` L`orrection$% FEMF++@ @@4 ף>@, BBBBBB@$$==_888% % W$l&oBy% % $$AA( F\PEMF+@<0B!BBBfEAB!BB!B@( $$=='%  % V,jr)%  % $$AAFEMF+*@$BBh>$?h>?h>.?h>@>?h>@O?h> [?h>??   % Tx[AA[L\measure % FEMF++@ *@$BBh>@ ?h>@)?h>-?h>5?h>E?h>S?h>??   % Tx^FSAA^QL\analyze% FEMF++@ @@4 ף>@<0 CCO4CC%#C'C)CB@$$==_888% % U,~ @  % % $$AA( F\PEMF+@<0%C{rB,CB,C~C%C{rB@$$==%  % V,u\  ^ \ %  % $$AAFEMF+@@4 ף>@<0rCBg"CzB+CvlB,CB@$$==_888% % U,MhZ + $  f% % $$AA( F\PEMF+@<0CQB CB CQ'BCQB@$$==%  % V,KSq a *q %  % $$AAFEMF+@@4 ף>@<0&BsC CBBQB8BGB/B@$$==_888% % U,/LX5Ha% % $$AA( F\PEMF+@<0BE CHBgOCSBR#CBE C@$$==%  % V,JWaS%  % $$AAFEMF+*@$BB"B(B6@|pmonitor>h>?h>&?h>w7?h>^??h>H?h>7Z?h>??   % TxhuAAsL\monitor % F@4EMF++@ @$cC3(@aCC( $$=='% % V0<^< Z Z^<^% % $$AAFEMF+@@4 ף>@H<cC!CC!CC3(@cC3(@cC!C@$$==_888% % V0< Z Z^<^< % % $$AA( FEMF+*@$BB8CRB6@|pmeasureE?h>@0?h>b@?h>3P?h>`?h>eq?h>@w|?h>??   % Tx=hAA=L\measure % FEMF++@ *@$BB8CuZB6@|panalyzec?h>5.?h>??h>@gO?h>@NW?h> g?h>Yu?h>??   % Tx@AfNAA@LL\analyze% FtEMF++@ *@$BB8C?6@@4C@ ?h>??   % TT8 >AA8LPC% FEMF++@ *@$BB8C?6@ orrectioni?h>/?h>:?h>E?h>@U?h>e?h> o?h>v?h>(?h>??   % T@ nAA@ L`orrection% FEMF++@ @@4 ף>@<07ICv CLCC C-ECCCvB@$$==_888% % U,qy* I[% % $$AA( F\PEMF+@<0C7BC>=BFPC_BC7B@( $$=='%  % V,q~  %  % $$AAFEMF+@@4 ף>@<0SCHBC8BiC۬BC /B@$$==_888% % U,{Idyn"% % $$AA( F\PEMF+@<0qCB8IC~B+C*ǛBqCB@$$==%  % V,rF~Ni*i%  % $$AAFEMF+@@4 ף>@, C)MsBC9B@$$==_888% % W$R"U>22?% % $$AA( F\PEMF+@<0CNABC0AdCNABCNAB@$$==%  % V,OW%M2mMM%  % $$AAFEMF+@@4 ף>@<0dhC|CCBۈCo0BC6B@$$==_888% % U, I5hz4% % $$AA( F\PEMF+@<0C CC C CCC C@$$==%  % V,(44/%  % $$AAFEMF+*@$BBCoKB6@|pmonitor>h>?h>&?h>w7?h>^??h>H?h>7Z?h>??   % TxcpAAnL\monitor % FEMF++@ *@$BB,CA@0$ۀ>ARIAL6@@4A<=3>??   ( RpArialArial V x5uV \w} Xی"||`|]|j|}|  @w|H& d|||}|:wQ!,w @w dv% TT8AA2LPA% FtEMF++@ *@$BBpCiA6@@4B<=3>??   % TT2AA,LPB% FtEMF++@ *@$BBd8DiA6@@4C<=3>??   % TT2AA,LPC% FtEMF++@ *@$BB`XDiA6@@4D<=3>??   % TTl2AAl,LPD% FEMF++@ Ld)??" FEMF+@ ObjInfoVisioDocumentiNVisioInformation"SummaryInformation(Visio (TM) Drawing iNdQ M`R |h ]||ȖPHp kY6:3l !fffMMM333IyUJ:DT5I[1hXT@. .Ub##/a0zGGz?K&[&/~&b%*~ !oL $c)PF?#~~,, & "& , 4&?Cp"/.?L74? T0A  }, ,,'p/%O6$X6 (}j?k)?"   34#o =S?#A:;A;dUdU@;dUdUdUAONOD`;dUdUdUdUdUdUdUUb SR~;4OL%=Qip;RRRggRtd=Qji .@]E' @%p3~|bFp#*| | | ui?Pb~OO:e,_/"/`LC%C%HD[CTY///////??(?OL?^?R_obei X_;-0GE(/6*___\q142qp?v?o?(v4||w Uo;_M_0/B&HDKAz)7I[m]Jd2b(#jtb8oJo\onoog?p+bw6Ӎ@C🖶x݈7@1y̠Ʀ̤MJO\OrH䪵x? ݈+C{j%ĂBRP?^\/j_|___/]3dO贁Nk&O5,l6 x߳+k#*Poo϶ vtͣ_ l:η7o\Iyї2b@bz`b.bLbݔbbtb}Hol^U)"}錄(J4( xr(; `w@!?w "*^p? N(Cl*S CUY` ,@,? LFDTyqC uhn rT UAbbd#@AZӅi?A3I"?FP 2~4@?oreuu`"5&"u- )*e@Z!Z! u-!#! R!%!E!!H!$>"$>-"'$>!"('>!(*>!(+>!(;$1>!(;!"(7>!(8>!"(:>!(<>!"(=>!(>>! (o;!(R>! (1;!(5>!(G :(![D!(U>!(V>D(W>%$X:@1!Kc!|i5y5!(U!y5-Dk7L?@ +{?@V?h ?@5cg'ؚu&u?o^!{/?8/cqZ!t! зt8zut?!r,`,׀1zuwD$_Pzux?(dp# " "(#v2%1xm"LM"- Q\zfU8#0O贁Nk(2l!0rU e!iD/-!BAzQr-:Qr>/0vA'dufxX5(uwy50Sw50Y@$mQ asurQ  i$1i&=ay4 '2qbE2!ǁfDhuSoeowooooooo| /ASewǒjvuyLJ(:L^pʏ܏$ß~ Ɵ Drzԯanlyz!3EWi{ -!ȿڴ!>Iϗ#1sU&8OTJC,?@(;?@>GU98?@MX?@OP0wu `u `b7u `u &$ @"4-(( @!^T#!"(!e#2" -"v$h.Gg ""' "&&"-i֯ݰu x?@ߟMݮݹ;M"Wxv͸/{?B Xg ѧ $@&7'!2'?5&G='O0\@?hOzF?eNA7f$ EŪ߼R1,7wgA]OkPG >#_iPm#OmtBє"$ :" QzחPd@?̜? "$4B£oo:gr#5F<$);M_q,3?@= #/&/8/J/\/n////-_P1u #$?.<xF6PJV?h?Ə=֍??ӊ b؀64.8NO`OOOOOOONaO __1_C_U_g_y________ oo-o?oQomuoooooou29qq5GYk}w/6c@$^?@v:"?@:*#.P-DT!?1CUgy ӏꃂQ # 3< `)?_ߥh\=v >Fn֐ v"̘U(347C5+EO q˯ݯ%7I[mǿ.c %T%G0?JM jz@/uχϙϫϽ //);R0YѐdYsm߀Ьў9Fd(9dFдTK?@Y 6?@V?h Z5cg'د?@BBHEk?P$E1 ǖ 4̓B,~B?4eÖBo*D@99 V҄8OҝL>N`@r.0ِ9UϾu//%!;(ϵSCZco/oeUnJEoo,+aFϾuo5eRoo{o;(%monitr# Ӭ9(5%XlWF.'V%%!'tQ 6%S$$YRd ?}߀???? OOU@ ?T?@p?@@@EcF@%qOOO ~Q +Os3 *+VҁYnBpk_}__;(=Iyř*rT_[__oo%o7o`-9тэ K ƬҝoU#oL̫cuϔOIJϞ}q2Կ'Aarjjp5"Gр1}4U(N1pE-|m쿈Q@?@O@@?*TTH]Üӟ埓 I,Ql,SȤ5KJp/j\![Nu.bBRU&&::(rNbb( $-0BWe)BŘ"N\^p^_f[:Ϭ#msap}ϡŜduܟ5k+O?l՟pXr!`moni+t/r'iOaAgyee凜 xXtp'2q!A飄&>!/(/:/L/^/p///ɤ(yUv @@:Ҕ(s/ |4Q!6P "2U6622Oʏ _oSew~_UA_"}kJn`"n$oPdi yR1}ōqj@@M?@l7;[I@@p3 ?N!J+q>yeX=CIy)Do@ -?Qf`ɯ@ۯ!IoQ r#bU = ,>@i{2&[ra`3"9#\aQEWi{oo XlF85 @@S, V .@RdQ+6 ߦ#5GYk}/*Q ?V_J\n____/"/4/F/a,GCx/!i/%/?R&.@@Y0?!zt)bK6U?g?y?a+v@?dv??}OOOOOOcwo2oDoϟ__>)bJooqΟVz%7I[mǿټ3qooooo 1CUU@zc$/@@Dyeٱu>.@RdvЏPbt*N#ޟfߊ8easue˯ݯ%7I['k}ſ׿ YE4FXj|ρ9%9U 1CUgyߋߝ /N r/?//!?/E?d//?;M5a:ayzrY*$- 2#DTf% .!(q .!II")pI '9wAyfn\3Da?ofd?40PA F4O" //1/C/U/???///*?7 `akat mxsh-+- @OSJ7_bs,A -a T}]J@@h?W?@WGU98?@MX?@OP0arauV``u+`?bu Pv6@"YȀ^a\T !__i.PDY pzk҅q{֞҉ȶ WGI`D?@NQn@@?qpp%qQ[% eoeao"M#0O贁Nkc ,favrooow/rlU(ԋwĢ]OkwPG ># j ΘmtR%:@ Qz忓̜? ,%4^aBRt r5^abı+¿Կ .@Rdv ?"w!Ϡƿ p+=OactA (236)636V2A=YE0<; )67(7'?>)6 G=V7OdO! :VASew+=Oas_+@ooK]u;|1ur_//RwĶzc$/@@T ?@PpI$"g@L"h-DT!υ///// //?\,q-3\~?4vv~4?w?ɠ6 ='>PᆅQIO[OOOOOOO3O__+_=_O_a_s___*]v@oQQ&?W4q`/ASew+(kX@@.J?@jʒ.?@q3þ?@uPרQ/ASewWkӠ-3 T҉_P4U_ւm3f8F&v@@|<`UT'U5?şן 1CUgyӯ _->o_M_UzV}P T=,^=oOoqd/j~d!3|w ;?f? }oboWۨpǿٿ!3E+(g/ @@.6?@v:"?@:_**%3'#u/ @1?X-3X 236P4 66:2%=, Λ:f?'Xjl6 67 7 ?> 67=:7?uHOO);M_qW5%j_],/T%"h0?JM jz@_|botoooooooo0qY;`7T`PSwQ=yE-W<_N_`U) ob?@V?h ?@5cg'بuzsWQ//Ӌq@ńhxORqL!E`UOO_#WQq02WqyQqQyh_U|__ XUv\BoWuu͟[[E^ n.WKt؟p]XT~frogwes t] haeI0 itCECΥ&XΟ 'YDĆΥ! 4⁊K Pt8#5GYk}065ˁ1y]"4DY}ŏ׏ 1CïկSw`?QG&O]X$]m)u7I[m򒿤ͷ`|a!3EWi{ύ /A4|a0vTfxߊߜb?2?7V?[(???p/J? O`Ean(lyz%7I[m<)4 ,3]/#, ! -DJ qq!catiQ?@WGU98?@e@R2b8gP0V!w0!u`u 0bu a pf]P@")1yhiha3oaibtac~bybd5.]Q]UQ r rw rvv?r*}dAX~tNGX%``W?@:"@@ؼv/?\RCvwrwuvw}?wpdA2)8\#T?L^D!V$?0PA öY$_E-##0OׁNkV#IF +0͆$!0/B/T/f' z".,5/U/9N:eROdOK)8dCc7iaOkpG >#?4/ΘmtepM Qz4~̜G? :e/ʒ@Br*s5a!]|=^_p___[____oo$a;O/oIo `oroooooooo} *s9thz|fv(UvbtcuƪvǴ2Dhz@)12ۀ`ߏ'9K]oɟ۟2fy HDVhzƯد@R>(:Lpʺ*K&b@@4;-?@jʒ.?@q3_?@ ר9A* ?KLH@@Ds[v&7't?->&b7.='l?߽? 2DVhzԇ&8J_x,UcSP*U X=,^)]\,( Q9!3|V ;f? cu_ o+sA  bAiZE(A(=IAZEcw1ZK?@;D?@Mwy֋8?@5cg'Su\uȄVA(P/b/utQa KIutr,Ͱuw\&}߰uw<^Dps![hcOBALREbOtOOO,NWK@EEa0GAIaig [OUO___9_@OXKUvw_E^u֟蟈ZEK%I[ fϟ@OXA@measur) iD^=yE^饔AXZDK'4!; ;v9Cooooooo(: <1GUgyiI %:^pʏ܏$6HZȯگƟA o`U1&akPnDzHF8$!CEo_WO6J@Rԟ$6?@V++?@h}?@M_XϤPÍ6k1E1u)0`u8p`bu ב]ޔCp@"o,՘11iSۑ*Ւ.M/_/vU.}ɁӢɅ }xB~&a!Щ$~ ;DoG^?9P-q=/ <^v/ hd/ ҽn N_$F2~~}!y}~Ʒпy5r?"5Y1?/7!e LH A[915E?W?i?(Gy:D)19CYuOcO^(o&o[o-WPz`5 yS0%w__mt_2m:M QzחR?̜? Ҁ411Bd"[m:r511"ɬсFʏ܏/߀$6HZl~$Fj雟`@̟ޟ&8J \n#  ԯ<1HpI$F &dI ;EW#@vA/?P?b?t?*="VO11YXkSX7QQ _[T(_8_J_\_n____6i@@Xw?@v:"?@:*/ҷgo.o@oRodovoo oS CDzm4/'?B,h t?}s2t3EzFǷ @Rdv'`ɏۏ#5GY>¥O??=T%XP0?JM jz@4-O?OQOcOuOOOO@)OAQIS#5G(Uaً{4 ?TPƚp?Z@@ekPv?P, hze ?`{, `u$6,{._qci9snz\ߞ=w/Iy 4Fߨ"s0[0sU fo]"H%bP &⠙5m//>v.?@?X렑}?/?s2/Z% SrA5B;Cܖ\I@נZʌ!@@}q;V?h ?@5cg'%UU.Uȏ]!Ϟ@liVsHdALjcu'/9/K/]/o//!O??R? ='Vo?o\?l0UO?tUoy Moo#[Xmo_nitYr iaU+ TeeqhXWK'ļf!kt-a+ &ݕQ&dOO$fON`rJhB}?@;/9%_7_I[i_зt8 ,`,1  k?s90=______na߮bz$e!o3oEoWoio{oo o>ob/S.ߒRqϚ=DNY Carec_iYfBщ/Y#鬠'2ӏ xfů@@UjpIț:!3r07&>% t!kqIR\OnO;MOOOOOO2>D@@0\H_/~ZYϯ)o 0BTf߮; ?.?R?btߚ?/?/F?Ot4JP9oUg;s@ _ @Wha@e3IBfQcﮋ%7FtSt.T]/ \ 1^ސA4w%?@*"^?7@xJb?7P-DT!R!,!u`u `bcu a2d P@"thhE!3abacbbduQ*vbX0m8?6g;0|;y=}\ݓ kE}gZ^ p tRC*v)w!r)w *v69w@ HwX|@!\[EP,˿ a a]D !e,/>/P/b' v"*w/U/*6O dPO?՗[cOh@7Ay_v _______ o@J0d̽Q?@X_S8%?@v:"?@:*/#,lgwoooooooo8.%rAQQ 3D $?sȚp~{j Ju֘{۷t{u{Afv N3Xv߬Џtn1CUgy1O.(NO`OK0d%T%OhP0?JM jz@?OmtԲlM:ղ Qzח忐̜? M?X?&@@Br:r5!$rQ̦T(1ĤQ (1(5 DU@_$@(>`?޵`?5y9$sTԿ q /b/t//诪//ޟ(=9{//}?9//O?n*)?/M?+Ol/??sO4@4AOOOO \2 S0UBՀ._@^ZX5yVr@ QT .7I[{{A.yfߢ//'/9/K/????/?/2?o/!z?E?Y?oo?9? MQQB'O9OKO]OoO OOOOLWOOO_!_3_E_W_i_{_S______n?iko/oAoSoeowooooo-?Q^+Ma/S7ϛ[ϿoCď֏ L?CUgyӟzv" 2DVn?i愯̯ޯ&Ϧϸſ ȿ "ϖFϺz|Ϟ&ρD+=Oas߅t4bbd#@ZӅi? DYBB@A-T3H7 ;Y@LmQR@KRH<(EmQ@ R\mQr 5t@1@@?mQ@.PDmQ@.PU1( UO"D&aUAUNj )h"T} U+U |ɉB&Q- -H*=(XiwEQ//,/feArial UncodeMiS6?/?`4 R$fSymbol$67fWingds*7 fEArial"z@D/ R$fGSwimun{a (  R$fGPMingLU{a (  R$fGMS PGothic{a (  R$fGDotum|"{a (  R$fESylaen  $fEstrangeloU dsa@`9$fGVrinda{ (  R$fEShrut1i$&<fEM_angl$$%>fETungaH"@&>fGSendya{ (  R$fERavi"&5<fGDhenu|"{a (  R$fELath#&<fEGautmi &<fGCordia New{ (  R$fGMS Farsi{{ ( _ R$fGulim"{a (  R$fETimes NwRoanz@D$UBEB|UbB.BUB%BlUB5BUB9B\U#C=BԂU`CCBLUC9BăUC7BB܉UVF8BTUFGBGuideTheDocPage-1"Gestur Fom aBlock }NrmaViso 103BSHE3BSHG3BSHG3 %KH%G34%KI"G3dU*IGt4bbd#@ZӅiC? @IA-tfB%7 ;%t4 fB_QJ A-@[7AJ@TJNR@ܞT]J6RH<(H<(JELTK RETK R{  w"4FX ,h(V@(4ǵ0;Zɼz "KN]BTdQ P ,kT`%y{<1@ CYB@kQ R$4lQR!l)Kr'ܡAh1?@ABCDEFPIJKLMNOQZRSUVWXY]^_`abcdefghijklmnopqrstuvwxyz{|}~C A?"?"[m Bܨ„'[K+@=[m Bܨ„'fXGȼkz[x̝ |ՙ_B$!@2.M)7!ə\pW 0!\0"Utu[TlI-]Zu[b7)JvZ+sfdxy'LyϹ<{~9=3&v,IB jY)7,y~L.V9Mчq^lMA\usשHBj[!/ytpoBan^ʠNI@)k\g"}Ey%wgX֤[|$:GƈX@+۵EįG1/>>5`VkCWMAflƚkxB؊ClH="|'y/דe.?(ޣdLH$oe\~Jו-MեKR3社K#KTg"DK1Zjp&5 Q?pȜhK.Iɜ${;i%\e (nDq&E oi"r 'koJ=h+>țh1ߞw#ɷpȜg$"8"6̥Llj.\W15TCcGN}"2΍L`Y4RnݗXzp}߲~sDW9;dmGxSo-MB(}r=3Dz:S%ǒ{mYhY^ѿGSgշ>@Ґ< _BEN \$"mm?uS59Tm7i!C$Gyr3W H>#^y·u ,7|N&7^>PQrY=kFg#3OA%4 /+"W;/&H<:Ag^pux9Z}֚oUsTYq|d:g?1U떮Z8h߷ϙX :| T6SG㳂Kc, Inh)ỞcH|#0߉. y9oB/,YuCjGF~'cQ&| yHd b/.`~¡;w~x2vB s'Ϯsd'x꼾5+Uxxc)|M njC:OƏkzoJ|7G:ǵMd&jF?L:t犉]h;/&# kwYȈer9h;'֙\)^U8uH{&V ^ c;fa3?ֵwjz.= B7i<${c[mDB^Te{UIP;:I:_Uט 1&2eߓI3hySN 2bϏVZx[cJx`]6댭C!fr1GvwvYOi[WT놪*֕?(@Ip wk%?nH1~At{;&܋yHd1kGe4.̙}:1uMS;J$޹+cl>B ϝe5׿\q^WÛWi^K4^C8#)f '!rs|=q]3z+wj?ۍa!.Eׅ ^ uyC֧W@S_ֺ֮c>xiw[vk}l{ZG}@I󿉾1@ a'iyJ_y-g2&ד6¬Mcb@2#v2sC+ ^!59oi{E+тMcJ5!l`}g,4v֧2Wi]w֩׺OUZl총Zso O:_Ok}%ASK/C"K~ ܕ|N Ie|Gxn)cJxb:ywj} xWKp,q,q1 Q}(O>/_I$:W,&r\؏ޮw']]frk\?h=_A6KuֺZozEkt>ʩ)9~ iǤMX6.g^;f}:0kɾ5mWČ]>C.'kz=YSdBS"3N-N߿72潃H]y(mcy!|LD|H[g`g{>Rw7?P KgI\B}*7mc^h5qYمOӏkmqkyvZ{L ڇhsW7GnxX_Һ+Z7֮eOiج\#M+9G$KiTT-gvs-T&s-b@'w} 8be`:.&CuF'">*~ZƜV~Lk ?{W{2gz3k  /6ۓ%7^+loܭoyXwnHg g 3IhQ^.~Trr$2Ns-:%d˵'"$F͝?]q;0p'J,䝣X e5fj6_ o(f7MD7\?cW[xoCZo =ZwZhJ|gf9_A sFFQ!9L8s@|=EELDE昌G}SW\NTExe=(-py&Wr] ]?]JDyԄK>hܗ|\+>&p\[TxuH$$i B|e$(cl>B ܯ;̤rdcdEhEڄ'y+yx9ZƥgGN`>G j3Z[럩_wUmSڄO .Ƚ*vqn:Jp/eG(ae=w{]=7;{OAHNY+=s'mE)kNg\ >[h):ʎ/7F:!k2-ܚ{eSǿyUNƍ:$޼2VVJ8oc|!‰mDڄ0,3r*km=W /GH^Qw_E~?Q)u>2%ۂ37vSiN%hVfug8ё0ۭS?uupg򷊦-9}9ɲvʻ2U8okXÐ)mYh.csOք'O ;>@͏2kmk-;|b-ώ̤?y ]+h/r"m‹`D=+Ϻȵs pxjɧOOڻkqÇnxO'NKΧ w.u J0I<] ߻mן;U[ONkͭa^km/o W>!k؅ȾYDց9Hg#ZWfQxODaT]}1~~IA=›V?LRMFVN$D}_S'q9>x>Woq%|e>B Mٛ{fuϷ>q}"mKu$Ş+|~' #0kc,+7Oi޼O=uy\֕nk]=k|/%h^›I^Y ?u2>k֕wcN]9QYӴRu|̙u/m2_u/뺳DƊH.t ]=챲O6ёmr(uxhCi^yXB_̃uf] NS}] /7{ߝ L]QK_ZNk#Y!nֺg۵G!'AƤ?6Xb땴kv uGxc)cJx>bgվSsz&>vUഒכ,SiNW4N% uOU;>gۄP|~ҟ>նl;髷i2gޮuG~y]Z/=軿_: ZW6iIhN`NMDb6'hKpϖ6ݲnBKbߏ!ΧJx>e=[--^^CWi^C4^ib uqJ+d<:fgڔoj}l|7պlSZ~ZgV "gQ;L62&J8=e;~SRkS-;ZhMx k$/g2]t$oP]4>]Cq%߯EGPkQҜuLI r9kg K)΋ /)O,WԵsHk>;Fw>CUg/ԺւEO8܋s(m¡`ơCd<>H"F]}oL[;2$߇ W\I[glIVr_J|wQi 'Y c=PkOrr6!j"y󃋯,&S_IZZkѠ? >GtQgA}E?W_J:J^ۈIǛԽ;{B G2|)4KL5hr-? 뾡֕?ԺׯL:kNr}">/&"9KGqG0s#:x&oN)y[K?\+hq"W8əvM(L^$1@nU: {cZVM3c5]C 3ǑzDLZ ^%n7'_ZJ/-1"Q6zSImJ/Ûi+P>;H1ZQdoxO+}'RpȜh^C֌`9C6!2'cV=ϔBOy}kv)c QcP]5[No9kK1.[tcpWW5!>vu+"28L+f ̤rdcևx/&ľWwv1֍PAVv; ^YsfOE7G3̠]lrO oZ4Vj9Z\kJOZu*SWlҺyVk vjܤj}W!B$h9#=k׉"bGL_ёf\d;]5jN_YJ S_G}~3{׵3ۯ*GQ|H[g{DerD3;IgS^鲗x/&/:.Mp2P^ނ#^-;^L\8۷^.?_~3!&k} Z?Xǵ~oZ{+Ni}ZMyJOk}eާ}"k[>;mi9ҽ2rh9>IHb.yO,qwg|^q=~ZO9\) -#Y.PoU~ֺy wd<]#l?Wyfi}~{^u+.k־uZXu-Z>Wuvi]>]Gj-[҉Q8dQO hB}_2ޜ` ::,+/y`r$1dKmݖ:)O]r9{Idx; ߑ?g 6_0D㿜RDz!QrC~覇oS̔z#[HA$檏W;Jڄ+&u.-^>֬Kޓgnmu_H[gri ~suHTXB RwȿMj=/ǵo{X7}_:ev 9Z~-2-nlǭzs䵼uY4kP?pBptq@ikZ3O7"/v-~"*ZVzC9d"]/N!K^s AR4%®HobOBL11י2D )"c::Z#3g֮BV$Yj-v{ru+Un LŞSC>|LU'1Q!%,Y)ю _51>lzV#aOS|:ᛦ͋"ee'xv=G5t#t骾O'שݽ=[y |s+z8㛫*{R`r hN=b k9>{vV3yʕTI`9!Nf==bl$s窦vO xbZf@9E Թ0O'|>b/i)u"#yB셪)Ο\ |TK*ЋE*.R!N|×W9ve'x< >~ͪvX5,P)` 9R]SO'E*7K,@a/R;>o vEog|KTerM&{`_qȧbuHY,^Z[q <ƷY}-U>9؇S]!NJ bk$Fbm{jmojc|}.ebC!\}:oiNWÇX}}a/S5}ӷ NKTc_r/9w&LU(g6cKw1{_2ŮHu}L]| r0u,Uj|M|:ᛥ[/G7`ߠZ[&bg9^\i˔;!ʰTV!g4鄯L TrXSW`PMvV<Ʒb[ZҖ@"L< 3t7[U>b^jV˓ކOzl'߫UC 1L'bQ&F9O'sTn|N'җ#W)Oj|F Uo#aS >9O'syb cX髱WvOx5Yξ(WJ 3UV!g6o:я#FbmW]<51o>ߍ%c d`\ħ>b/c Ua'x<ŮvV5_# &F9O' T.cɽoTv|5_%vgߕr@ ,AʱUOl Bu?GZ쵪>{v@gkH\,^rfNՉ16XTbWvO xb[Zި؋չ0>9O'|T@r} \N <6|뱝|oP kUc&9If.^3MrfN>Lr/×;s=zɴ<2}}TJD"-^*rN @f%{jmO4JW`rp2e*k!gHo:Al8hAv6<ƷbۨZoP`rpr\ħ>{#FWaoT56Ozl'ժaO5!CnA1>&>|ܠr{pـTcW+;Mj'vEM2J,r0k UeM|:[[`G!7v6 <ƷYC}oV{:{j|M|:[N[cGY7,;[U[s1mQ-CU`z {:'g4o&6>|{jǷ_amĮvU5 ۤm@aa&F9O'UaV3̎_Į{Yk+TpOl _:Ola`רv ֫jч/_.]jknW0SԩwjtnrzQl>6\7&vޭƹ{`oSF#UUb'g|<1މaש<'c|2^KGQ7QƇ!bXN[#16܅ޣN'x nR-;Qjju.Oΐ51|lT#Fߨ^j(;}ۆO쇱ojݣ%sM؛T}Qh>6\r/wRrraSrn{^=ͪr^a498{m5<r=b}'f{IborI!ǐc`oQYc95ňq:Al=b}t~h;k+xoߊ2fzgnCيU 3ZM [U5# cnEmcw_ƶal;ެ[ǒckkTX<1|Ԩܱ>cqcn{^=߭r~aGN'xc_xw9CU}ĺs<Ʒ alM5U=:f8{ob3'ZX}3ޏW "^=aU90aM 'ޥ*&|rfko:?#36{ 1~.&'Rgwf^dzy.o>bإN0zta_|NW?v ?$=sԅvn#\#yFPqI ZD# X5xKzWGKؤuG}E!Js_Zd"qbtg2A3]rtLr^I¡LWw'KPH]e%#&g>|aa|~  gΞ-ߜ{f;0B2ffA > ?8,b1QN;\{Afiw#"]LjtWY Kg*bXUmzɝ| K_-930>>#vq N͜A f og,|/4cO4^糈/wwvwto:7ا?]n7|Z"X[b|)|NGgG٪=kl}p$;Տ+zO_9'u*8y~8-eYS߿G6=,1Wnv74bg+"K>!xC7:%oH{ຬNkOUP==ȵW3ESJ]pjF;uݫ I9m׹_)R0d02 gz *=g F9} 1t_Ou_wu_O'>c;L;{>a|D"!ۉ#rf C`@Q|w/1%|| BGܑ? !9w|1g,| }_;B׹ ^'| f3}7C > _1$8XVkC"),dAA@)OT PzQ @QFŊVTQ|E-3svo.w'aMdO̹w{̙3ww5vZCtCY~W%Ku0[7Δmˇ|H0Y~[p6mg@~\]l:|<-u/gw>Y~)/CtݾVߖg `y-Ks.l,ja_4p7'asn?Fubh^O? ;*CTGZEl͍ L6fn-- z T;pS KL;8 uQw$c8F(#pa5bfSC7n 1kү= A A-'@FރI&vlͭ* B *swl b֤YhO)V6g͓A~5vZ__ݣ1k6_m\ %]`ʶ177m 1k_U; o1ko}>/ я5__{d`:V~ fMmhc)z<Z`~+ߵZw-[V{#fM݆+P kA\Z}3֤&kS% Z=WR#\wXYޓ>VXΟ}+Тܣy>s_@-KWl\?u[>^G.ܝ H0]~ӗ*eY/ux~yY q_]~_:K~Я1tkя5w_KXWW ~@o)7zԑC>J=tw8؏5oCm-|׏{`~+L٦5S^S;uH#fM@tҡ_ t~}56<77m~ĬIhHm$8m ث5CtCY~W%Ku0ۏ{`~Wפ|_>/mχ@b?b֤ uc_?q_]~_ ޟo>^G_ ޝz$&R_:K~/}\.Rm澚2yXP&5pepl)?k5pS.n OG4ԭa].H0CJxsNIxo=0jǹ5e}Ǥ)M'u]@A? əػՔ@+h!maAb~"±M7T<8G|\.SZZm{+[ݿ=7ye 0})p)=ګCZJAbA~^3D+f}vtI;8#2αj]ZLA39M&WUr<ѓV+˻ṷ6XUfU6Z Yi?4l2jMԹP2)M,/uV_o]R7-ods~{'r~=?AG*Ξg;;o< >GQZt\D*Q^'g\ ϟ zB̼\}0> h ț t~wSv˜W#ȽI^'eTqQ| L䙚Od;n>yy FOa*ub܆Tݧ<߈# r_ˠbp=8]c|!c@cY*-6ցj2 X Λԙ63-gFӦb[9Y-;`Ek/6c_KaŠK+.ϕ]!ϔD={Ő-'1LޅBgǯ5毼ۭa:'(X FKmJwC k0Dbi%nY:O䏛vU]e!ۛvFĔ(nZc޸IMǸilk^lBmTi!b`>Sd6̙ :ms}F8 /xEfÜkSd6s0m0`̆9-sql0L01;$UaH@Y'ΝsS}{qN.G1Dog.g95HfmHo]'6w;)an^o;UGNO>>xL䴓؋\G^Kh\M?x/cA([}n_2+9)vs*FZ5 ň/s5Rn۲[/ţ眪|7ǻ/VeGQ<}sR?yuΑrĻj=gtBL%yJuyKMj=+l4e( (^HzM葍Q?؈'y ))2&@L^3/Sd6L0EfÜc3 )v0g`f̶"aN <` sVf#<Sd6̋0"+_J  ,k 2ŏy#&w<}|uLq|R'qG{;۹0moX$7qS:9:q8$"G$`awx/Qqv?޳Ck()Gu >\{Q,\" wƟwv]MtUݹ=tİP˯:]:Wor-k]ˣ+Hy󵹖 YNB sp|lsU:H9.Sd6̙a9"Sd6̹ &B]d60A"aщSy"aNг^ /xEf ~L0CJ`v L2Sd6̠#Uils/d)"aHHb2,REf GBLb1Ef,C=p?l{(yL;Wkm|7gx-)/߀O Ic<20AՉ9d,DLb1EfÜXx sZf`J sn&cIl 'c!b4Sd6PfO?Sd69 fL0`g0C"aQIl}$2eeLb1EfÔu 1"aT۪T$Sd6y蟼ƂRܞ"a3)Sd6iJmg,D= |cQ$Sd6L]Q?L|M"L׀곧^h3\N[3+;E|u㳧~;%rIE.#??{\+?s~}J*7bUs#/ N U¨ZYZtFVE,NT<|@ŝϴDb0Ef j؀Eυ"aUugQ~L0׏ 0EfÜzLj7~=EfÜM@$t!c%;>èBO@lY?.6|A{oT# )G rܩ\?f37֦Q6̥WsKrIE.#;Wo<r^K4"yTs apؽ9DN7zJQks+nܑW\ţPܽ,å~xUO}5-Uu}Kx"`Ӈ23U'>g$Sd6y3Sd69?1x!um١b69"aVzTgd\R\O0g`66-0EfÜj0zWO0`Lbol!Uw7;A=ر5/87M6{d-׼;@_q=i]^Ï4kG*R} -Ǖxn gf%.8g"a L0Fx!icEf` =O4'`̆9-:R"a^`v szL0;$Q]@]a!.(Ӯy3DfGU|+䕠duh=2P뻹}e:nVy\iN}y/xf_LCc fL0)=A)ߓ)2\'4)qSd6̲=cx!)2?>=߂1EfümglIL[z̆4׾o0%nb̆μg0m 3zLdAɎrԝB+k5c/t0쨿TQ14 Y۝T6 vqom]-`Wj[X!DicSU w%GwxZ>+Xūߨx;/}~Ã7j?*{_QYw}r$=؏cG-x|_;Ɵ: )\kȹwxL.deC7S\댼mZgm+[;KDY"ۗXε{Zg|=cGε{~AsN"ǬZ&̵ߡK._VuW,AoQ<4ŝ#:j?=:?Yc'e țlkYC##9ˀ62|d{2!}U[\>ysf"FF+'?O ;^ =\Iϛu<[[ *~z6/]"acTn,E{c'&ߦBXmc7@{0&(̪'}f׫UBm#x: /5UIJ*0X˗Dw~:VSYrUO*Bmku9myw)F~xK>`Ve{2A0SJ%][ bUb}SyvP6$vƎ](ulRţ7wi%]#/]灯ڜtټr=N_VO أ.1=F \ UfTqW=iL6?Ա9u0v:.RƆ:@ ŷټu@[oQSX!o^'/@aG<1Dv+9u=f=mo=rc޿P9/*5-yJ6?T?:t څzv1څ$:uwef-.!lñ ~bL:jmj*wV p%+/kp-yB ;#K==߻Rx? wB 9{uS%x:;NO]*^Պ^D=\\m4 34 I__!cPIϽv>^c}(2?JP9uK@H>!\=+ܛN諸zPjx02m> osͩ_"Oh?r&w-zܣ;+ _qjv!Z[<4s+x/x;.yWܹtAw(nx? z4q=v.=  I#;2-QX-m:e.%&\zAvR%yǎ"4OQ 9cYdt'ǽZħ<P|ybəSV/$7:e{8ovn1|[q; eXA3HTP v 3pWi;K_p7 :?O.xu뀿TW>X ȁuDm(2NI4gjLMM=|r< `u?>1jlO758c"n9ȇ'fFb`\c I.S΀+gvfh/o`JȐE Dv:|_:a3fn[ۼ9ɑמq*FDF/i{wDbaG{[]ww M@̋-ys7Uŋu{KRN8+.:0׮[Tt~k.qgÿ85:>o(}斫_{|$&?  ^nOvbZ컻1_Y ?36q%peRg \;c]X\1qg 0&X~O6uK݄W$^bpQ^apupbx}=ZYOc?O?6"UO<ʿrmW \ikZh/>7'f+?9oÚck;I(o7v'=v쀒d^ RI|Ο!+cPi(| }@Rc@=qTSo^WPzZ@Y VJ8[!k b@l_*}DyK _Ref241461027}DyK _Ref223375282}DyK _Ref223375282}DyK _Ref223375282Dd6 L  C A?"?"$Ju5]?V+@=Ju5]?_Nx\ |ELf$@cB `ЀP4!UZ0qyވEWUU\]}S3&y/__] ! N(XbS1KY 6D Q8Q|ז2$gUpq)*I@u݃⑀#8\w&0o0BxuT"Œ AuU۫BBL0V7 T s@_r5svz'X&2&YW2?7J8=8!RT Ĺ$Ol(8-׾ୌm԰PCEzk~tv E D$gg6q Vj,EPPҊz4=,~Rp; }dT_JWjr2v< `?e/eP'}mqLO}s^i1BoRͮQ>t:QoEib'w'V~6Q ۊJ^R7mq, x-RgU˗bq-Df/>_ }Μh}m#PB.yvq!|1<[xupjփLbOd;d8 Vm{< &-~8㴍f"8^B1*haTy?R.sg˽glWݓQ"?d,)^gOxE,tƒ>n- 3|u.JuKTOPc͢fJOЎ Eڴ>(pQǼ Z8"g%2g~~j󅸐oG U)G:ο*hm9(>#R/ ͛gB+J{=pp./! /Y4̐[U_Jt25s^1 O3ץ@9]'N?GBݿ'cns;M-L-?C=MV7[u&_˾N}xF]omn}zNArZՄ3tXſ3V_tf-~az{[|fe}Ppx خ78һj߼Ԛeo ` w_dпUM˶K{"-^HajA="Kpخ<>[MkB6uA/lKգe 8oM|ousǦ17Yb\aa-T_~G}'U/1x&kL!.N݃c `9[A3>M7A冎Co*4a\j<8 7Ukŵ; {'~{bn4\:;bg fot=>]ldM.9vq&{{bkU 4Ye?cyO?(D0.3E̢<ت1f%xg:ٻǫub^l1<jYgӽ6o d&{$`sGZhq,ذ@I8&lVޭV2Bџ^ΙjΖN܆}tS<;3m=lEҪΨ]|霝C(]o.-8~2ҿ.)m u61zYQ4(ccec8jbg*.sx vo)_+%}7(Zl 2X# mܡq1Y-8tiog1/roEh~)ƥşŹ\( t6;sqÇWQ5kph?)9Mvuwջ߬F?w:a 7mњu5io ԠOt9RrJJ_?7|fn^hL;S[j o^eM7g7[` FYb\:wʾ[6غsq``md?c3]w O9=b zLp|GR@eb=/_mL^;3Hm _a[q=<lb\DžiѰ\*D {oL΀0-c78&5BdxV+r紅sFh7{i0ƃQN &-tm׶8KIX2l v/]Pq-v]^z@'k}Ye[\q)K-K+Ҏh4'\jyJ}Iz/ueZ 5<Pɲ˸:v0D{wZsʲBփ%wca#'n%SSL]w^`)K$8V3OHpLdKi.8&jۖi/}6|lv%QZK8lǟZ4 d (X6c/NMS[䁯ZvDLk }Y=D(ۮ ]͵y}ԫl`׎p?[V_iwljZ+=nrӦY|x\z9_oQﺞK'!Li xޟz=kǵ}~$)}dh}浴WwO@{#x^"f~zZNi<7]@{`6 Y8NPt QP1Pך&$MKm=Mx7@`_A906;JǩQU5wf.m ad 烼/hu8 &\97( i_\޵Xw/|ۃ݋6/ 9RvZQ)Vy'Ez=_uD?85}+;g'W<}ZBfI.խ@j\e>w%U ݱ >eBE8TS( ߍ5ZiVmʮ8=ha=ma&E0q`*11쬳;{U-#Fzo7ko_&AkT2+IsQ礰D?7wO)zum󺏴OFhѮ.*zmnr gcΕJྡ\\oT9`sz-dp ͦ\\UU٥K{c5r`,.9T&N):G)K-nbg֊׵ TQ>q{ ؟v;-xfw*NO y'9g}x0jGwEX_~P ?D^g|N_<ּv*W!kN:PLԕ>3Pï>o{D%SSL|nrg'~CK x-q>%)րRGwk@}J-θMu'd+ɳ| =sMj@z` \ .3~\ս߭AsoU{uZzX|[p0қiYK},*},fp3^`&5SoGB\.]f([OShHfLoFAdè8AR(DG"AJ/ScL~ A煓-fX< ,5.}vחiϷ-?v,A$_ǣ-x(pܻ~h[ߟUnCN}_~fa<@+31Dqǖ*UƷy,LjE p;{MګA7. zZl;ҮcpE,f0ϦmچPe9e}"텿I_YǴ wMCpo ^y|mkY_7_b-ػd}>=4ivnRCZoF&η%`>7ߋw&9ߊyɸ/{k^ x pk+Wϗ OڥwvFj]&GB8s48v~-w*¦Hn5чg2*K~-Gkio :A'ǂg79zGo -zqE |p /i+ yS_pB }F7_fОc_ 0xTDdv-RZ=^el 0GG读7g?v=F'S|,Zگ0.o3fZgv3}ֽhS=+7`et\AU9H7k2!鿌3^܋&5^8MݽK71d3ptj:`?Sǣ/`X_Te>2̌/8^'kY~:~e[tIB|]o\^׀T37@[`s _zap}s7eߥLKBV=>3\zz䥶7Co@=z`Z}@=D:0PiX RLh_z5/Y; ~nb7`_q^pp^seoCpa[ 4J{$$If!vh5h5 #vh#v :V l t065h5 / yt\1$$If!vh5h%#vh%:V l t065h%/ /  yt\1}DyK _Ref223375282$$If!vh5h5 #vh#v :V l  t065h5 / pyt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$$If!vh5h5 #vh#v :V l t065h5 / yt\1$$If!vh5h%#vh%:V l t065h%/ /  yt\1}DyK _Ref223375282$$If!vh5h5 #vh#v :V l  t065h5 / pyt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$$If!vh5h5 #vh#v :V l t065h5 / yt\1$$If!vh5h%#vh%:V l t065h%/ / yt\1$$If!vh5h%#vh%:V l t065h%/ yt\1$$If!vh5h%#vh%:V l t065h%/  / yt\1$$If!vh5h5 #vh#v :V l  t065h5 / pyt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$$If!vh5h5 #vh#v :V l t065h5 / yt\1$$If!vh5h%#vh%:V l t065h%/ /  yt\1$$If!vh5h5 #vh#v :V l  t065h5 / pyt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / / yt\1$IfK$L$l!vh545#v4#v:V l t6545/ / / yt\1$$If!vh5h5 #vh#v :V l t065h5 / yt\1$$If!vh5h%#vh%:V l t065h%/ / yt\1}DyK _Ref223375282}DyK _Ref241462777}DyK _Ref241462753-Dd*r STL  C A?"?"3D X 8w`X"i+@=a3D X 8w`X"H>Hd؀/x[ tTٞ$ $C(~cLچfw@HcF H @-i*QRR0zVm僈GiHTJP[>̝dC ;'̝̽QBY@7B71=EϨq%BL¥;h! vi]H@d Btԓ$k?r[ TcD~fQ_%c_aX" aOnuwA|N_2`;>CaR,_@:7o=nc&9:%;X~5Zzlutcm:F z"@= Pxc]C5ֈ)As,]:iQQQuť{ƹ8aKXoC̢(ٿZ3u ƁSY:q4q g$qȴr I,`$PW]vD=6j$lvٜ㚋1KQ7͍5wg<0Fƾ'{4ԧDH7NJߨ[풫oLɞwJk $XgJ[yd]%'D=.;,)Mсomm˫4@~Sm:,%itsor .Gqm h9GeF;"65h|n!I\% ]\Ũ$FMϪ |7Ok7Fotպ_nt746͗vG``e+Pq<4X `DxxXN v/o!lRY ,0sj8.o_"=b͟, O+{~.?m'n֪WO^.< t{lw 9>?,]Rk?ḯ/ 8kS34ǹDmrg h+k`)!@Mt.vc/P!>z rQQ ]zB#z`}+`"գc gڇ 0*1L23F)#,=׭uu# }ԅKgQY댵Zf؛HY\:}܍LbR#cO"h%a>cjf*~z< _]8̉+@BZi]_[킝.ȴmXBcc"yJ065D%vCu" aV7>PX t39޹/Lvwoz<{Yy{<}mr |t*׷\ =6fFpuDvp-Й̙%[ kG9ٮ2IӶ.Ѕ>µ'\g$sdjs>|>UJ=`>>&.yޘ\Νځ] >S&;^5GEuOIn{Tuw?#ٸeo&|u֦Ŋ[v'Hd݂[1{1-\k똦xkP3g P%3rjqOށbFgz'&(Fc 7g!7zom } hz("5kQچuD|vG YsCߨvI jA}orsG]@ah|\'EN wpw1.9ٳ6 sυb1 ]8gݿPz-۩)teH6>"z(O٫T_T>@I.R?2}dOSu6.klØ[>) (E4svw~}ҧzNMjؙq[S|/^aT8\ǚ?Sw:7{ƶӹ ~>XB ۅҷ^ =z|܆uD<7Q= {+ujJn]NxBQA^5 aNH! A`w^Esˇj:٨c ڴs!+35|Ԇ+}Ì}e9} m4/+Ϭgj.p?c7}ѣ+N=JpKφRWU&9 l ]G]m3}XB 3S@ j7U: 7~1Tǒ>SU{Q%3T{b-i^ڛj 1}Ԙn/wVgZ|^}MKh< ^/x~(xZ4 m}JŻг/*7oʌl({>j>>mĀ>jޣ 67p!#k{zGm9B140ksw"BQnh [|BsфL.vD}H'A_GS\@ M\RL|Q{ cjAN }$ T Bٌd ͕fؚHse ƮPpf.<؟4J˕l~'vIJxjߋ兩>ę~{)Kޅg y2@ZGyohala.l%46a; D>c(|:DDw|n~شde%ܺO"e}%Yť'G+ɪ=`K$.r iC|L Kgѱcx]T?CI6f YBu"d-Pz͟(K$y}!>2]_*pGj0pjN5i>>vvd@a; ?(Azq_$w'B>Ž^Rmo+O`A67q*tz.pJ1q8e&uEc@W`z}OoGSo}6{3g*䷱l:$ax ȵic^hEg{jMnҿz_ܬb&[[3dftb-7{Oj/wN_uC}#~~1RN#<*h_ f?0Sn\]G vnܿZߩ_ߗ+7~O/FnNq[=W*2nֵ-毇_&㈷`~oȢDoY;_ݿn.5+zml'm͗ba`>dsw/fqwUn|C{}Yr?~t ;D|h@VP 〕}DyK _Ref241471920}DyK _Ref241463272}DyK _Ref241464087}DyK _Ref241464109}DyK _Ref223375282a$$If!vh5 5[#v #v[:V l4 t65 5[yt-E^$$If!vh5 5[#v #v[:V l t65 5[yt-E^$$If!vh5 5[#v #v[:V l t65 5[yt-E^$$If!vh5 5[#v #v[:V l t65 5[yt-E^$$If!vh5 5[#v #v[:V l t65 5[yt-E$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5/ yt_g$$If!vh5 5#v #v:V l t0&65 5/ / / /  yt_g$$If!vh5 5#v #v:V l t0&65 5/ yt_g$$If!vh5 5#v #v:V l t0&65 5/ yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh5 5#v #v:V l t0&65 5yt_g$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1$$If!vh55J 5b#v#vJ #vb:V l t0%55J 5bayt\1t$$If!vh55#v:V l05SummaryInformation($HDocumentSummaryInformation8. Macros;r;rVBA;r;rvices Guidance on corrective action and preventive action and related QMS processes - 4 November 2010GHTFghtf document templateAntezana, Sebastian4Microsoft Office Word@@@}@1\@.Y p՜.+,D՜.+, hp|  `o GHTF SG3 - Quality management system Medical Devices Guidance on corrective action and preventive action and related QMS processes - 4 November 2010 Title (X`  _PID_HLINKS_NewReviewCycleAT >*_Toc264194105>*_Toc264194104>*_Toc264194103>*_Toc264194102>*_Toc264194101>*_Toc264194100?*_Toc264194099?*_Toc264194098?*_Toc264194097?*_Toc264194096?*_Toc264194095?*_Toc264194094?z*_Toc264194093?t*_Toc264194092?n*_Toc264194091?h*_Toc264194090?b*_Toc264194089?\*_Toc264194088?V*_Toc264194087?P*_Toc264194086?J*_Toc264194085?D*_Toc264194084?>*_Toc264194083?8*_Toc264194082?2*_Toc264194081?,*_Toc264194080?&*_Toc264194079? *_Toc264194078?*_Toc264194077?*_Toc264194076?*_Toc264194075?*_Toc264194074?*_Toc2641940730* pHdProjectQ(@= l 9R J< rstdole>stdoleP h%^*\G{00020430-C 0046}#2.0#0#C:\Windows\SysWOW64\e2.tlb#OLE Automation`ENormalENCrmaQF  *\C m! OfficgOficg!G{2DF8D04C-5BFA-101B-BHDE5gAAe4 2ggram Files (x86)\Common \Microsoft Shared\OFFICE12\MSO.DLL#P 1 Ob Library'|wfThisDocumentdiraThisDocumentj_VBA_PROJECTyPROJECT F(G T@hisD@JcuJen@p 2 HB1ŠZ@B,!T["B+BBw[xME (S"SS"<(1Normal.ThisDocument8(%HxAttribute VB_Name = "ThisDocument" Bas1Normal.VGlobal!SpaclFalse CreatablPre declaIdTru BExposeTemplateDeriv$Custom izC1a *\G{000204EF-0000-0000-C000-000000000046}#4.0#9#C:\PROGRA~2\COMMON~1\MICROS~1\VBA\VBA6\VBE6.DLL#Visual Basic For Applications*\G{00020905-0000-0000-C000-000000000046}#8.4#0#C:\Program Files (x86)\Microsoft Office\Office12\MSWORD.OLB#Microsoft Word 12.0 Object Library*\G{00020430-0000-0000-C000-000000000046}#2.0#0#C:\Windows\SysWOW64\stdole2.tlb#OLE Automation*\CNormal*\CNormal9R4*\G{2DF8D04C-5BFA-101B-BDE5-00AA0044DE52}#2.4#0#C:\Program Files (x86)\Common Files\Microsoft Shared\OFFICE12\MSO.DLL#Microsoft Office 12.0 Object Library 9R wThisDocument035239cbbcThisDocument[ %iJ9Ù7` %WordkVBAWin16~Win32MacVBA6#Project1 stdole`Project- ThisDocument< _EvaluateNormalOfficeuDocumentjT ID="{19D10E6D-4AED-4D8A-9BCF-8BB14A87D726}" Document=ThisDocument/&H00000000 Name="Project" HelpContextID="0" VersionCompatible32="393222000" CMG="9290B3234127412741274127" DPB="242605D5056606660666" GC="B6B49747BB4B4C4C4C4CB3" [Host Extender Info] &H00000001={3832D640-CF90-11CF-8E43-00A0C911005A};VBE;&H00000000 ThisDocumentThisDocument  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89qPROJECTwm)CompObjy^7 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ uXNormalCJ_H aJmH sH tH b@b 2n7 Heading 1$$ F @&^5CJKH\aJJ@J n7 Heading 2$ & F@&5\<!< n7 Heading 3 &@&mH sH BB n7 Heading 4$@&5CJ\aJDD n7 Heading 5$@&`a$5CJHH n7 Heading 6$@&6B*CJ]ph3fpp n7 Heading 7?$$@&NOPQa$588 n7 Heading 8 $@&a$T T n7 Heading 9 $@&^B*CJOJQJ]^JphDA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List 4@4 n7Header !4 @4 n7Footer !`C` n7Body Text Indent^h6B*CJPJ]nHph3ftH8B"8 n7 Body Text B* phB@B n7TOC 21$7$8$H$^`0CJaJJ@J WETOC 1$ 1$7$8$H$^`CJaJNYRN n7 Document MapM OJQJ^J>> n7TOC 3$ ^p`0CJaJ** n7TOC 4^** n7TOC 5^** n7TOC 6^** n7TOC 7^** n7TOC 8^** n7TOC 9^6U@6 n7 Hyperlink >*B*ph>@> n7 Footnote TextCJaJ@&@@ n7Footnote ReferenceH*@"@ n7Caption xx5CJ\aJPRP n7Body Text Indent 2!^ 6B*phHS"H n7Body Text Indent 3 "^`JP2J n7 Body Text 2#6B*]mH phsH HBH n7 Balloon Text$CJOJQJ^JaJB'QB n7Comment ReferenceCJaJLQbL n7 Body Text 3 &8qB*mH phsH .(q. n7 Line Number<< n7 Comment Text(CJaJ@j@ n7Comment Subject)5\\\ .P MM Topic 1 * F<$CJ KH OJQJ^J_HaJ mHsH^!^ P MM Topic 2 + F<&6CJOJQJ]^J_HaJmHsHb1b P MM Topic 3, F<8 CJOJQJ^J_HaJmHsH88 PMM Empty- _HmHsHdd *PMM Topic 1 Zchn.5CJ KH OJQJ\^J_HaJ mHsHtH jj := Table Grid7:V/0/b/b dDefault 07$8$H$-B*CJOJQJ^J_HaJmHphsHtHNON X_Standard Text bullet +1 FV!V WEHeading 1 Char"5CJKH\_H aJmH sH tH :O2: 4WE GHTF_Heading13 FF"AF 3WEGHTF_Heading1 Char CharHTRH 0L Block Text5]^p`0 _HmH sH :Ob: 6 Headind Annex6 FPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  0RU < |< nnN f YM7oV T$z&(**,&.%01689<@ tv|  (@A^g:Kgijl   ,>Z\]_|2NPQSp8:;=Zq  + T p r s u  % A D E G d q  8 ; < > [ t  ' C F G I f }    / R n q r t  !#@gEadeg'>'B'111=?h?l? M7M;M [4[8[[[[\\\h___bbbnnnq+q/qMqxq|qttt|||bm&QUǢˢ  X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%̕::W!!8?"$m Bܨ„'["$Ju5]?"$3D X 8w`X"i# AA@H 0(  0(  B S  ? _Toc264194073 _Toc264194074 _Ref190480223 _Toc264194075 _Toc190215324 _Toc190226345 _Toc190215325 _Toc190226346 _Toc264194076 _Toc264194077 _Toc264194078 _Toc264194079 _Toc264194080 _Toc264194081 _Ref241459143 _Toc264194082 _Ref241471982 _Toc264194083 _Toc264194084 _Toc264194085 _Toc263932425 _Toc263932426 _Toc190226358 _Toc190214686 _Toc190215345 _Toc190226368 _Toc190214687 _Toc190215346 _Toc190226369 _Toc190214688 _Toc190215347 _Toc190226370 _Toc190214690 _Toc190215349 _Toc190226372 _Toc190214721 _Toc190215380 _Toc190226403 _Toc190214722 _Toc190215381 _Toc190226404 _Toc190214723 _Toc190215382 _Toc190226405 _Toc190214726 _Toc190215385 _Toc190226408 _Toc190214728 _Toc190215387 _Toc190226410 _Toc190214729 _Toc190215388 _Toc190226411 _Toc190214730 _Toc190215389 _Toc190226412 _Toc190214731 _Toc190215390 _Toc190226413 _Toc190214739 _Toc190215398 _Toc190226421 _Toc190214747 _Toc190215406 _Toc190226429 _Toc190214749 _Toc190215408 _Toc190226431 _Toc190214750 _Toc190215409 _Toc190226432 _Toc190214755 _Toc190215414 _Toc190226437 _Toc190214757 _Toc190215416 _Toc190226439 _Toc190214758 _Toc190215417 _Toc190226440 _Toc190214770 _Toc190215429 _Toc190226452 _Toc190214772 _Toc190215431 _Toc190226454 _Toc190214777 _Toc190215436 _Toc190226459 _Toc190214779 _Toc190215438 _Toc190226461 _Toc190214789 _Toc190215448 _Toc190226471 _Toc190214790 _Toc190215449 _Toc190226472 _Toc190214791 _Toc190215450 _Toc190226473 _Toc190214793 _Toc190215452 _Toc190226475 _Toc190214798 _Toc190215457 _Toc190226480 _Toc190214800 _Toc190215459 _Toc190226482 _Toc190214801 _Toc190215460 _Toc190226483 _Toc190214802 _Toc190215461 _Toc190226484 _Toc264194086 _Toc264194087 _Toc264194088 _Ref241464109 _Ref241464123 _Ref241471920 _Toc264194089 _Toc232430395 _Toc232430396 _Toc232430397 _Toc232430398 _Ref229715931 _Toc264194090 _Ref229715964 _Toc264194091 _Toc223401544 _Ref241460976 _Ref241461027 _Ref241461044 _Ref241462462 _Ref241462865 _Ref241462883 _Ref241464087 _Toc264194092 _Ref223375282 _Ref223375288 _Toc223401546 _Ref241462777 _Ref241463272 _Ref241463287 _Toc264194093 _Toc263932435 _Toc223401547 _Toc264194094 _Toc263932437 _Toc263932438 _Toc263932440 _Toc263932445 _Toc263932446 _Ref241462753 _Toc264194095 _Toc232430404 _Toc232430406 _Toc232430408 _Toc232430409 _Toc232430417 _Toc232430420 _Toc232430424 _Toc232430426 _Toc232430433 _Toc232430436 _Toc232430443 _Toc232430449 _Toc232430452 _Toc232430455 _Toc232430456 _Toc232430457 _Toc232430463 _Toc232430466 _Toc232430468 _Toc232430474 _Toc232430476 _Toc232430477 _Toc241457329 _Toc241458593 _Toc241458652 _Toc241458724 _Toc264194096 _Toc241457331 _Toc241458595 _Toc241458654 _Toc241458726 _Toc232430491 _Toc232430492 _Toc232430493 _Toc232430494 _Toc232430495 _Toc264194097 _Toc232430500 _Toc232430501 _Toc232430502 _Toc232430503 _Toc232430504 _Toc232430505 _Toc232430506 _Toc232430507 _Toc232430508 _Toc232430509 _Toc232430510 _Toc232430511 _Toc232430512 _Toc264194098 _Toc241457334 _Toc241458598 _Toc241458657 _Toc241458729 _Toc241457335 _Toc241458599 _Toc241458658 _Toc241458730 _Toc241457336 _Toc241458600 _Toc241458659 _Toc241458731 _Toc264194099 _Toc264194100 _Toc264194101 _Toc264194102 _Ref241479253 _Toc264194103 _Toc264194104 _Toc2641941054 3!!""##$&1111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111n4CIIIIIIIIjMjMjMjMjMjMQQqqqqqqqqqqqttttt WWWWWWWWWWWWWWWWWWWWWWWWWWWfffffffffffffX!  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~> =!!"" # #$%&11111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111114DIIIIjMjMjMjMqMqMQQqqqqqqqqquuuuu  00WWWWWWWWWWWWWWWWWWWWWWWWWWWWpffffffffffffi!??VVVVWWWW3XNX``ddLgPgjjInPn\rer $%wxxzz{{}~ !$xxzz{{}~ !_!t/r }u*3Hu. 8I#t^{H^ &,fV(H:*+,2U.D~[;"rPTzO[" Zn#Lo*c1&)~J}/?fY1vDw<K^D6>^,IfPQpQ.U[v P1qdwhv[f)̝%hDAn>yGqԃ)Nw< APy%xS{,U hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o   ^ `OJQJo(   ^ `OJQJo(xx^x`OJQJ^Jo(o HH^H`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo( pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(PP^P`OJQJ^Jo(o   ^ `OJQJo( hh^h`OJQJo(^`OJQJ^Jo(o ^`OJQJo( pp^p`OJQJo(@ @ ^@ `OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(-^`OJQJ^Jo(o   ^ `OJQJo(   ^ `OJQJo(xx^x`OJQJ^Jo(o HH^H`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(^`B*OJQJo(ph\^`\OJQJ^Jo(2\2^2`\OJQJ^Jo( \ ^ `\OJQJ^Jo(lz \z ^z `\OJQJ^Jo( \ ^ `\OJQJ^Jo(\^`\OJQJ^Jo(lf\f^f`\OJQJ^Jo( \ ^ `\OJQJ^Jo(^`.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.h^`^`.8^`..^`()^`()pp^p`()  ^ `.@ @ ^@ `.  ^ `. hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo(P^`P.0@@^@`.0^`0..``^``^`^`^``^``00^0` ^`OJQJo(^`OJQJ^Jo(o   ^ `OJQJo(   ^ `OJQJo(xx^x`OJQJ^Jo(o HH^H`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o   ^ `OJQJo(   ^ `OJQJo(xx^x`OJQJ^Jo(o HH^H`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(DD^D`OJPJQJ^Jo(-$\$^$`\OJPJ QJo(\^`\OJQJ^Jo(ll \l ^l `\OJQJ^Jo( \ ^ `\OJQJ^Jo( \ ^ `\OJQJ^Jo(lX\X^X`\OJQJ^Jo(\^`\OJQJ^Jo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( hh^h`OJQJo( 8^8`OJQJo( ^`OJQJo(  ^ `OJQJo( ^ `OJQJ^Jo(o x^x`OJQJo( H^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(\^`\OJQJ^Jo($\$^$`\OJPJ QJo(\^`\OJQJ^Jo(ll \l ^l `\OJQJ^Jo( \ ^ `\OJQJ^Jo( \ ^ `\OJQJ^Jo(lX\X^X`\OJQJ^Jo(\^`\OJQJ^Jo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o   ^ `OJQJo(   ^ `OJQJo(xx^x`OJQJ^Jo(o HH^H`OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o   ^ `OJQJo(   ^ `OJQJo( xx^x`OJQJo(o HH^H`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(PP^P`OJQJ^Jo(o   ^ `OJQJo( hh^h`OJQJo(88^8`OJQJ^Jo(o ^`OJQJo(   ^ `OJQJo(  ^ `OJQJ^Jo(o xx^x`OJQJo( HH^H`OJQJo(^`OJQJ^Jo(o ^`OJQJo(~[;"fV U[/r NwI#thv[f#{^,IvD_2UxS{%hK^D3fY1pQyGqAPyqdc1&O["^An}/                                                                                            yxx                                           \B*                  xx                                                            K_@os"}!'Ohio"#7Se]6ev /4a<=Y1l} 9P@-EnWkn|0D{KjXf^rv  u 3 ! 7 L ^P r` i k i ] @H HI ui i  UB JO Gs %,a5vp|%7;R%&0\p^yt+#<lmyx&v~GbZ[+s}0QM'@NO`ijv6^W^s{JG{G'%k:5k,4h9HZmR$/2S{i%.d<FUhp5w|{~~ YF Q R D\ !; !)9!O!Q!3Y!Tb! *"="]i"l"I#m#$$$U $+$sI$^$! %4 %G%n%z%m&4&V&\]&ih&'''' '''a'''-'^B'['+ ((/(K(i(l:)JK)eq)* *9*G*[* a*f*-+u+b+ ,,",_",D,Q,"-P/-7-M-W-.s./G/^/0W0/70.:07@0^0j0\1 1U1[%10<1L_1s122+2/2h1282gE2Sh2 3!#3234!4UE4|e4,?5K5z56f6h/6hp6n7'7g7Ji7K}7X8 8t#8C(8.8K8um8Gn8OD9qe9f:M:!Z:7y:+;pU; t;HA<s<u<:=3A=P=>.>-E>O>j> r>x?C?@@|!@z4@8@ A6 AMAZApAYBWC?CjHC{C*D4DADYFDKDrqD E8EbE]nE{E\F+FF5F08F G>GeGG2G>OGNcGO\HeHSnHpHvH5I*eI~IJJJ8OJ0`JzJ-KKBNKPKMtKLwLDLlLsLDzLMMC(MLf_g.gRgq`gcglg=h+Yhihi'i0ij- jDjj}#j5jpZjb knkk-k@.kM0kQDkEkpkl l'l'lTpl,m:m:n5n8n}HnQ o)o,vovopipGpipq3q4qrY'rPrRrnar-qr&~r sF*sY.sNHsKt%t- t+KtUtntrt@u)Xuv;vAv%TvZv wiuwxw2x\Wx\xlxdy$y(ySyzu zz2Zz?{ { C{M{pP{h|j|@|uk|Zl|G}uT}Dr}#~$~+~.>~}_~ 4;<MAoyDOOy=QNT`f.abf(f??dC4|P0q3bM,{w& Fb~q'%{%$BKK4Z^mYxI#:r~. Hdx67#HW ' 3{:A&bdu^,u+!';-@"gs&&@v-"Dt ";F DUhs~B)WE"G) 472Qfn CY _&0WBIO_adcp5 =x43Q99H=0M"?o5,9afj--h}syJgu"26NP Xau9y_0SeZvB| Z\@p Se]7kh 'JCVW_ve tUk"oYCj}$ad!#B14b?`|q/Sry.:14EJT0`K] OKQ)k{ >sas 55/\X/O3]]$ (m<X`jyzS"CFIOXj )uK myNr}-I[`lpufccs <EPhg{<g#*y17Qj f+7A%v5B<$HsHxPi4qD|A $ 5u>yy?R&Zos!f"-2(;[Ce]!3QX-P\PzY59[{V1L^}I$y-2=cN Xir!-7DPsz7Tgdq:NXmA'bduza(-RZbku5vG05=h^hkx/>WZb.}| #zv'[)282FoWPl5wRxSuv%'@ X@Unknown G*Ax Times New Roman5Symbol3. *Cx ArialY CG TimesTimes New Roman;|i0Batang;(SimSun[SO5. .[`)Tahoma;Wingdings?= *Cx Courier NewK=   jMS Gothic-3 0000A$BCambria Math"1eG h po po02HX  ?q`g2! xx}D:\Documents and Settings\212008401\My Documents\GHTF\GHTF Steering Committee\Procedural Documents\ghtf document template.dotGHTF SG3 - Quality management system  Medical Devices  Guidance on corrective action and preventive action and related QMS processes - 4 November 2010GHTFAntezana, Sebastian